testRI is a study to find out what is in Rhode Island’s local drug supply.
You can get the most up-to-date information about the local drug supply from the testRI study on this page. You can check monthly for new information about the local drug sample supply and testing. Find out about how the study works and how to get involved. This two-year study is funded by the Foundation for Opioid Response Efforts (FORE).
It is important to know that the samples we collect and test only show us a small part of the drug supply in Rhode Island. These results may not represent the broader drug supply in the state.
Go to: Updates | Spotlights | Testing Results | Substances Found | Resources
Local Drug Supply Updates
How do supply updates work?
One of the study’s main goals is to see how drug supply changes impact people who use drugs in our community. This study tests used equipment, like pipes and syringes. We collect equipment from the community and donations from individuals or local organizations. We test samples using advanced confirmatory toxicology testing (LC-QTOF-MS). All testing takes place at the Rhode Island Hospital toxicology laboratory.
What do these results mean?
Our results show that local drug supplies are volatile and change often. But it is important to know that the samples we collect and test only show us a small part of the drug supply in Rhode Island. These results may not represent the broader drug supply in the state. We also don’t know whether what we tested led to an overdose.
Want to see more updates?
You can visit our Local Supply Update Archive to view all past updates.
Substance Spotlights
The samples we test contain a lot of different substances. Below are spotlights on a few substances we have found. Click on an image for more information.
What have we tested?
Below is a list of all the samples we have tested. We show where we collected samples and what substances we found in each sample. We also show the substance the person thought they were using under the “sold as” column.
Legend:
O = Opioids; S = Stimulants; B = Benzos; C = cannabinoids; A = Other active cut; M = Starting materials/byproducts;
H = hallucinogen/dissociative; * indicated substances that make up most of a sample
| Sample | Month | City/Town | What was tested | Sold as | Substances found |
|---|---|---|---|---|---|
| 1 | 2022-05 | Providence | Clear crystals in baggie | Crystal meth | Methamphetamine* (S) 4-ethylamphetamine (S) N-ethylamphetamine (S) Pholedrine (S) Fentanyl (O) Para-fluorofentanyl (O) Acetylfentanyl (O) Tramadol (O) Xylazine (A) Cocaine (S) Ketamine (A) Diphenhydramine (A) Buprenorphine (A) Byproducts: Benzoylecgonine (M) Starting material/byproducts in fentanyl(s) production: 4-ANPP , Phenethyl-4-ANPP (M) |
| 2 | 2022-05 | Warwick | Clear crystals in baggie | Crystal meth | Methamphetamine (100%) (S) |
| 3 | 2022-05 | Providence | Baggie | Fentanyl | Fentanyl (O)* Acetylfentanyl (O) Acrylfentanyl (O) Para-fluorofentanyl (O) Xylazine (A) Tramadol (O) Methadone (O) Phenacetin (A) Ketamine (A) Acetaminophen (A) Lidocaine (A) Nicotine (A) Caffeine (A) Starting material/byproducts in fentanyl(s) production: Despropionyl para-fluorofentanyl, Despropionyl meta-methyl fentanyl, 4-ANPP, NPP, N-methyl norfentanyl, Phenethyl-4-ANPP, Norfentanyl (M) |
| 4 | 2022-05 | Providence | Syringe | Fentanyl | Fentanyl* (O) Para-fluorofentanyl (O) Acrylfentanyl (O) Acetylfentanyl (O) Methoxyacetylfentanyl (O) Morphine (O) Tramadol (O) Xylazine (A) Ketamine (A) Methamphetamine* (S) Cocaine (S) Benzoylecgonine (M) Acetaminophen (A) Lidocaine (A) Nicotine (A) Caffeine* (A) Starting material and/or byproducts in fentanyl(s) synthesis: Despropionyl para-fluorofentanyl, Phenethyl-4-ANPP*, 4-ANPP*, NPP, n-methyl-norfentanyl, Norfentanyl (M) |
| 5 | 2022-05 | Providence | Cooker | Fentanyl | Fentanyl* (O) Para-fluorofentanyl (O) Acetylfentanyl (O) Xylazine (A) Tramadol (O) Methamphetamine (S) Cocaine (S) Ketamine (A) Acetaminophen (A) Lidocaine (A) Nicotine (A) Caffeine (A) Starting material/byproducts in fentanyl(s) production: Despropionyl-parafluorofentanyl , Despropionyl meta-methyl fentanyl, 4-ANPP*, Phenethyl-4-ANPP*, NPP, Norfentanyl (M) |
| 6 | 2022-05 | Providence | Syringe | Fentanyl | Fentanyl* (O) Para-fluorofentanyl (O) Acetylfentanyl (O) Buprenorphine (O) Methamphetamine (S) Cocaine (S) Levamisole (A) Aminophenazone (A) Methoxetamine (A) Ketamine (A) Nicotinine (A) Lidocaine (A) Phenacetin (A) Acetaminophen (A) Caffeine (A) Starting material/byproducts in fentanyl(s) production: Phenethyl-4-ANPP, NPP, norfentanyl (M) Byproducts of cocaine found: Norcocaine, Ecgonine, Benzylecgonine , Ecgonine methyl ester (M) |
| 7 | 2022-05 | Providence | Syringe | Fentanyl | Fentanyl* (O) Acrylfentanyl (O) Para-fluorofentanyl (O) Acetylfentanyl (O) Fentanyl carbamate (O) Codeine (O) Morphine (O) Tramadol (O) Xylazine (A) Alprazolam (B) Methamphetamine (A) Cocaine (S) Ketamine (A) Methoxetamine (A) Lidocaine* (A) Mepivacaine (A) Nicotine (A) Caffeine (A) Acetaminophen (A) Benzoylecgonine (M) Starting material/byproducts in fentanyl(s) production: Norfentanyl, 4-ANPP, Despropionyl meta-methyl fentanyl, Despropionyl para-fluorofentanyl, Phenethyl-4-ANPP, NPP, N-methyl-norfentanyl, Benzylfentanyl (M) |
| 8 | 2022-05 | Providence | Cooker with two cottons (*note: donated together and may have cross contamination) | Supplies reported as only used for fentanyl | Substances in both cooker and cottons: Fentanyl* (O) Tramadol (O) Para-fluorofentanyl (O) Acetylfentanyl (O) Xylazine (A) Methamphetamine (S) Cocaine (S) Diphenhydramine (A) Gabapentin (A) Ketamine (A) Lidocaine (A) Quetiapine (A) Caffeine (A) Xylazine (A) Quinine (A) Nicotine (A) Starting material and/or byproducts in fentanyl(s) production: Benzylfentanyl (minor); norfentanyl (minor); 4-ANPP (major); despropionyl para-fluorofentanyl (minor); phenethyl-ANPP (major); NPP (minor) Substances found in cottons only: O-desmethyltramadol (O) N-desmethyltramadol (O) Acrylfentanyl (O) Norketamine (A) Codeine (O) Morphine (O) 6-acetylmorphine (O) 6-acetylcodeine (O) Phenacetin (A) Substances in cooker only: Procaine (A) |
| 9 | 2022-06 | Providence | Baggie | Fentanyl | Fentanyl* (O) Para-fluorofentanyl* (O) Lidocaine (A) Starting material/byproducts in fentanyl(s) production: Phenethyl-4-ANPP*, 4- ANPP (M) |
| 10 | 2022-06 | Providence | Rock | Crack | Cocaine* (S) Levamisole* (A) Hydroxyzine (trace) (A) Byproducts of cocaine found: Benzylecgonine , Ecgonine methyl ester*, Ecgonine, Norcocaine, Cocaethylene (M) |
| 11 | 2022-05 | Providence | Baggie | Cocaine | Cocaine* (S) Phenacetin (A) Levamisole (A) Methamphetamine (S) Fentanyl (O) Cotinine (A) Gabapentin (A) Lidocaine (A) Caffeine (A) Byproducts of cocaine found: Benzylecgonine*, Ecgonine methyl ester, Ecgonine, Norcocaine, Cocaethylene (M) |
| 12 | 2022-05 | Providence | Baggie | Cocaine | Cocaine* (S) Phenacetin (A) Levamisole (A) Lidocaine (A) Methamphetamine (S) Delta-9-THC (C) Gabapentin (A) Caffeine (A) Aripirazole (A) Acetaminophen (A) Cannabinol (CBN) (C) Disulfiram (A) Byproducts of cocaine found: Benzylecgonine*, Ecgonine, Ecgonine methyl ester, Cocaethylene (M) |
| 13 | 2022-05 | Providence | Two pipes packaged together | Crack | Cocaine* (S) Levamisole (A) Aminorex (A) Byproducts of cocaine found: Benzylecgonine*, Ecgonine, Ecgonine methyl ester, Norcocaine (M) |
| 14 | 2022-06 | Pawtucket | Pipe and choy | Crack | Cocaine* (S) Levamisole (A) Nicotine (A) Aminorex (A) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine, Ecgonine, Ecgonine methyl ester, Cocaethylene (M) |
| 15 | 2022-06 | Pawtucket | Pipe stem and choy | Crack | Cocaine* (S) Caffeine* (A) Levamisole (A) Hydroxyzine (A) Phenacetin (A) Lidocaine (A) Nicotine (A) Aminorex (A) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine*, Ecgonine methyl ester, Ecgonine (M) |
| 16 | 2022-06 | Pawtucket | Pipe stem and choy | Crack | Cocaine* (S) Levamiole (A) Aminorex (A) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine, Ecgonine, Ecgonine methyl ester, Cocaethylene |
| 17 | 2022-06 | Warwick | Baggie | Crack | Cocaine* (S) Fentanyl (O) Methadone (O) Levamisole (A) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine, Ecgonine, Ecgonine methyl ester, Cocaethylene (M) Starting material and/or byproducts in fentanyl(s) production: 4-ANPP (M) |
| 18 | 2022-06 | Providence | Pink pill bottle | Percocet | Fentanyl* (O) Xylazine (A) Acetaminophen (A) Para-fluorofentanyl (O) Diphenhydramine (A) Cocaine (S) Delta-9-THC (C) Tramadol (O) Cannabinol (A) Procaine (A) Lidocaine (A) Acetylfentanyl (O) Levamisole (A) Caffeine (A) Phenacetin (A) Papaverine (A) Noscapine (A) Starting material and/or byproducts in fentanyl(s) production: Phenethyl-4ANPP, 4-ANPP, Despropionyl para-fluorofentanyl, Norfentanyl, N-methyl-norfentanyl (M) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine |
| 19 | 2022-06 | Providence | Rock | Crack | Cocaine* (S) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine, Ecgnoine, Ecgonine methyl ester (M) |
| 20 | 2022-06 | Providence | Baggie | Fentanyl | Fentanyl* (O) Starting material and/or byproducts in fentanyl(s) production: 4-ANPP, phenethyl-ANPP (M) |
| 21 | 2022-06 | Coventry | Cotton | Fentanyl | Xylazine* (A) Fentanyl* (O) Acetylfentanyl (O) Parafluorofentanyl (O) Acrylfentanyl (O) Cocaine (S) Lidocaine (A) Caffeine (A) Tramadol (O) Starting material and/or byproducts in fentanyl(s) production: Phenethyl-ANPP*, 4-ANPP*, NPP, Norfentanyl, Despropionyl para-fluorofentanyl (M) |
| 22 | 2022-06 | Coventry | Cotton (purple) | Fentanyl | Xylazine* (A) Fentanyl* (O) Cocaine (S) Acetylfentanyl (O) Para-fluorofentanyl (O) Delta-9-THC (C) Levamisole (A) Phenacetin (A) Tramadol (O) Methamphetamine (S) Starting material and/or byproducts in fentanyl(s) production: Phenethyl-ANPP, Norfentanyl, 4-ANPP, NPP, N-methyl-norfentanyl (M) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine, Ecgonine methyl ester (M) |
| 23 | 2022-06 | Providence | Foil | Fentanyl | Fentanyl* (O) Acetylfentanyl (O) Nicotinamide (A) Acetaminophen (A) Caffeine (A) Methamphetamine Lidocaine (A) Cocaine (S) Parafluorofentanyl (O) Xylazine (A) Starting material and/or byproducts in fentanyl(s) production: 4-ANPP*, Phenethyl-4-ANPP, Norfentanyl (M) |
| 24 | 2022-06 | Warwick | Cooker | Dope with fentanyl | Fentanyl* (O) Procaine (A) Acetylfentanyl (O) Quinine (A) Para-fluorofentanyl (O) Acrylfentanyl (O) Tramadol (O) Caffeine (A) Xylazine (A) Starting material and/or byproducts in fentanyl(s) production: Phenethyl-4-ANPP, 4-ANPP, Norfentanyl, Despropionyl para-fluorofentanyl (M) |
| 25 | 2022-06 | Warwick | Cooker | Dope with fentanyl | Fentanyl* (O) Procaine (A) Acetylfentanyl (O) Quinidine/Quinine (A) Para-fluorofentanyl (O) Acrylfentanyl (O) Tramadol (O) Starting material and/or byproducts in fentanyl(s) production: Phenethyl-4-ANPP*, ANPP, Norfentanyl, Despropionyl para-fluorofentanyl (M) |
| 26 | 2022-06 | Providence | Spoon | Dope with fentanyl | Fentanyl* (O) Acetylfentanyl (O) Methamphetamine (S) Parafluorofentanyl (O) Cocaine (S) Xylazine (A) Lidocaine (A) Acrylfentanyl (O) N-ethylamphetamine (S) Caffeine (A) Levamisole (A) Amphetamine (S) Acetaminophen (A) Starting material and/or byproducts in fentanyl(s) production: 4-ANPP*, Phenethyl-ANPP*, Norfentanyl, NPP (M) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine (M) |
| 27 | 2022-06 | Providence | Cotton | Dope with fentanyl | Fentanyl* (O) Xylazine (A) Methamphetamine (S) Parafluorofentanyl (O) Acetylfentanyl (O) Lidocaine (A) Cocaine (S) Acrylfentanyl (O) N-ethylamphetamine (S) Heroin (O) Levamisole (A) Midazolam (B) Amphetamine (S) Caffeine (A) Acetaminophen (A) Procaine (A) Codeine (O) Starting material and/or byproducts in fentanyl(s) production: Phenethyl-4-ANPP, 4-ANPP, Despropionyl para-fluorofentanyl, Norfentanyl, NPP (M) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine (M) |
| 28 | 2022-07 | Providence | Baggie with white powder | Heroin | Cocaine* (S) Fentanyl* (O) Lidocaine (A) Hydroxyzine (A) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine (M) Starting material and/or byproducts in fentanyl(s) production: Phenethyl-4-ANPP, 4-ANPP (M) |
| 29 | 2022-07 | Providence | Cooker with white and purple residue | Fentanyl | Cocaine* (S) Fentanyl (O) Levamisole (A) Caffeine (A) Acetaminophen (A) Xylazine (A) Acetylfentanyl (O) Phenacetin (A) Methamphetamine (S) Starting material and/or byproducts in fentanyl(s) production: Phenethyl-4-ANPP, 4-ANPP, Norfentanyl (M) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine, Ecgnoine, Ecgonine methyl ester, Norcocaine, Cocaethylene (M) |
| 30 | 2022-07 | Providence | Cooker with cotton | Fentanyl | Cocaine* (S) Fentanyl (O) Levamisole (A) Acetaminophen (A) Caffeine (A) Starting material and/or byproducts in fentanyl(s) production: Phenethyl-4-ANPP, 4-ANPP, Norfentanyl (M) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine, Cocaethylene, Ecgonine methyl ester, Ecgonine (M) |
| 31 | 2022-07 | Warwick | Pipe with choy | Crack cocaine | Cocaine* (S) Levamisole (A) Caffeine (A) Hydroxyzine (A) Phenacetin (A) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine*, Ecgonine methyl ester, Ecgonine (M) |
| 32 | 2022-07 | Providence | Baggie, white powder | Cocaine | Fentanyl* (O) Lidocaine* Cocaine (S) Acetylfentanyl (O) Para-fluorofentanyl (O) Acrylfentanyl (O) Levamisole (A) Phenacetin (A) Starting material and/or byproducts in fentanyl(s) production: Phenethyl-4-ANPP*, 4-ANPP*, Despropionyl para-fluorofentanyl, Norfentanyl (M) Breakdown products/metabolites/intermediates of cocaine found: Norcocaine, Benzoylecgonine (M) |
| 33 | 2022-07 | Pawtucket | Cooker, clear crystal | Crystal meth | Methamphetamine* (S) Cocaine* (S) Phenacetin (A) Fentanyl (O) Levamisole (A) Lidocaine (A) Ketamine (A) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine, Ecgonine methyl ester, Cocaethylene (M) Starting material and/or byproducts in fentanyl(s) production: Phenethyl-4-ANPP, 4-ANPP (M) |
| 34 | 2022-07 | Providence | Cooker with cotton greenish residue | Fentanyl | Fentanyl* (O) Acetylfentanyl* (O) Parafluorofentanyl* (O) Cocaine* (S) Gabapentin Lidocaine Levamisole Caffeine Xylazine Phentermine (S) Methamphetamine (S) MDMA (S) Tramadol (O) Acetaminophen Phenacetin Acrylfentanyl (O) Starting material and/or byproducts in fentanyl(s) production: 4-ANPP,* Phenethyl-4-ANPP, Despropionyl para-fluorofentanyl, Norfentanyl (M) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine, Ecgonine, Norcocaine (M) |
| 35 | 2022-07 | Warwick | Pipe tip and choy | Crack cocaine | Cocaine* (S) Phenacetin (A) Fentanyl (O) Caffeine (A) Acetaminophen (A) Levamisole (A) Xylazine (A) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine, Ecgonine methyl ester, Ecgonine, Cocaethylene (M) |
| 36 | 2022-07 | Pawtucket | Baggie, white powder | Fentanyl | Fentanyl* (O) Lidocaine* (A) Cocaine (S) Para-fluorofentanyl (O) Caffeine (A) Starting material and/or byproducts in fentanyl(s) production: Phenethyl-4-ANPP*, 4-ANPP, Despropionyl para-fluorofentanyl, Norfentanyl (M) |
| 37 | 2022-07 | Pawtucket | Baggie, white powder | Fentanyl | Fentanyl* (O) Acetylfentanyl (O) Starting material and/or byproducts in fentanyl(s) production: 4-ANPP*, Phenethyl-4-ANPP (M) |
| 38 | 2022-07 | Pawtucket | Baggie, white powder | Fentanyl | Fentanyl* (O) Acetylfentanyl (O) Starting material and/or byproducts in fentanyl(s) production: 4-ANPP, Phenethyl-4-ANPP (M) |
| 39 | 2022-07 | Pawtucket | Baggie, tan powder | Fentanyl | Fentanyl* (O) Xylazine*(A) Caffeine* (A) Starting material and/or byproducts in fentanyl(s) production: 4-ANPP*, Phenethyl-4-ANPP (M) |
| 40 | 2022-07 | Providence | Cooker wrapped in blunt paper | Fentanyl | Cocaine* (S) Fentanyl (O) Nicotine (A) Cotinine (A) Starting material and/or byproducts in fentanyl(s) production: Phenethyl-4-ANPP, 4-ANPP, Norfentanyl, NPP (M) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine, Ecgonine methyl ester, Ecgonine, Norcocaine, Cocaethylene (M) |
| 41 | 2022-07 | Providence | Cooker with cotton, black specks | Fentanyl | Fentanyl* (O) Cocaine (S) Acetylfentanyl (O) Diphenhydramine (A) Starting material and/or byproducts in fentanyl(s) production: Phenethyl-4-ANPP*, 4-ANPP*, Norfentanyl, NPP (M) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine, Ecgonine methyl ester (M) |
| 42 | 2022-07 | Providence | Pipe and choy | Crack cocaine | Cocaine* (S) Nicotine (A) Phenacetin (A) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine, Ecgonine methyl ester, Ecgonine, Cocaethylene (M) |
| 43 | 2022-07 | East Providence | Cooker and cotton, white residue | Fentanyl | Fentanyl* (O) Cocaine (S) Acetylfentanyl (O) Para-fluorofentanyl (O) Lidocaine (A) Xylazine (A) Levamisole (A) Tramadol (O) Methamphetamine (S) Acrylfentanyl (O) Methadone (O) Nicotine (A) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine*, Ecgonine methyl ester, Ecgonine, Norcocaine, Cocaethylene (M) Starting material and/or byproducts in fentanyl(s) production: Phenethyl-4-ANPP, 4-ANPP, Despropionyl para-fluorofentanyl (M) |
| 44 | 2022-07 | West Warwick | Baggie (white rocky residue) | Crack cocaine | Cocaine* (S) Phenacetin* (A) Methamphetamine (S) Levamisole (A) Breakdown products/metabolites/intermediates of cocaine found: Norcocaine, Benzoylecgonine (M) |
| 45 | 2022-07 | Pawtucket | Cooker with cotton | Fentanyl | Fentanyl* (O) Xylazine (A) Para-fluorofentanyl (O) Lidocaine (A) Methamphetamine (S) Caffeine (A) Phenacetin (A) Acetaminophen (A) Heroin (O) Tramadol (O) 6-Acetylmorphine (O) Acrylfentanyl (O) Procaine (A) 6-acetylcodeine (O) Quinine (A) Carfentanil (O) Levamisole (A) Ketamine (A) Starting material and/or byproducts in fentanyl(s) production: Phenethyl-4-ANPP, NPP, Norfentanyl (M) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine (M) |
| 46 | 2022-07 | West Warwick | Aluminum foil | Fentanyl | Fentanyl* (O) Cocaine* (S) Methamphetamine (S) Phenacetin (A) Levamisole (A) Tramadol (O) Acetylfentanyl (O) Starting material and/or byproducts in fentanyl(s) production: Phenethyl-4-ANPP, 4-ANPP, Norfentanyl (M) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine, Ecgonine methyl ester (M) |
| 47 | 2022-07 | Warwick | Cooker | Fentanyl | Fentanyl* (O) Cocaine (S) Phenacetin (A) Tramadol (O) Lidocaine (A) Acetylfentanyl (O) Para-fluorofentanyl (O) MDMB-4en-PINACA (C) Caffeine (A) Acetaminophen (A) Phentermine (A) Methamphetamine (S) Acrylfentanyl (O) Xylazine (A) Levamisole (A) Nicotine (A) Butyrylfentanyl (O) Starting material and/or byproducts in fentanyl(s) production: Phenethyl-4-ANPP, 4-ANPP, NPP, Norfentanyl (M) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine, Norcocaine (M) |
| 48 | 2022-07 | Pawtucket | Pipe with black residue | Crack | Cocaine* (S) Methamphetamine (S) Phenacetin (A) Levamisole (A) Fentanyl (O) 6-acetylcodeine (O) Ketamine (A) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine, Ecgonine methyl ester, Cocaethylene, Ecgonine (M) |
| 49 | 2022-07 | Central Falls | Baggie (clear crystals) | Crystal meth | Methamphetamine*(S) Cocaine*(S) Fentanyl (O) Lidocaine (A) Para-fluorofentanyl (O) Xylazine (A) Tramadol (O) Starting material and/or byproducts in fentanyl(s) production: 4-ANPP, phenethyl-4-ANPP, Despropionyl para-fluorofentanyl (M) |
| 50 | 2022-07 | Central Falls | Baggie (dark residue) | Fentanyl | Tramadol* (O) Lidocaine* (A) Fentanyl (O) Acetaminophen (A) Cocaine(S) O-desmethyltramadol (O) Para-fluorofentanyl (O) Acetylfentanyl (O) Xylazine (A) Caffeine (A) Diphenhydramine (A) Methadone (O) Methamphetamine (S) Acrylfentanyl (O) Starting material and/or byproducts in fentanyl(s) production: Phenethyl-4-ANPP, Despropionyl para-fluorofentanyl, norfentanyl (M) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine (M) |
| 51 | 2022-07 | Central Falls | Cooker with cotton (purple residue) | Fentanyl | Fentanyl* (O) Acetylfentanyl* (O) Xylazine* (A) Caffeine* (A) Acetaminophen (A) Para-fluorofentanyl (O) Lidocaine (A) Methamphetamine (S) Tramadol (O) Cocaine (S) Starting material and/or byproducts in fentanyl(s) production: 4-ANPP*, phenethyl-4-ANPP*, Despropionyl para-fluorofentanyl (M) |
| 52 | 2022-07 | Rumford | Cooker with cotton | Fentanyl | Fentanyl* (O) Para-fluorofentanyl* (O) Caffeine (A) Lidocaine (A) Xylazine (A) Tramadol (O) MDMB-4en-PINACA (C) Acetaminophen (A) Phenacetin (A) Methadone (O) Acetylfentanyl (O) Starting material and/or byproducts in fentanyl(s) production: 4-ANPP*, phenethyl-4-ANPP*, Despropionyl para-fluorofentanyl (M) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine*, Ecgonine methyl ester, Ecgonine (M) |
| 53 | 2022-07 | Rumford | Cooker with cotton | Fentanyl | Fentanyl* (O) Cocaine (S) Para-fluorofentanyl (O) Acetaminophen (A) Lidocaine (A) Methadone (O) Starting material and/or byproducts in fentanyl(s) production: phenethyl-4-ANPP*, 4-ANPP, Despropionyl para-fluorofentanyl, norfentanyl (M) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine (M) |
| 54 | 2022-07 | Central Falls | Baggie (white powder) | Fentanyl | Fentanyl* (O) Xylazine (A) Para-fluorofentanyl (O) Methamphetamine (S) Lidocaine (A) Cocaine (S) Acetylfentanyl (O) Acrylfentanyl (O) Butyrylfentanyl (O) Heroin (O) Tramadol (O) Starting material and/or byproducts in fentanyl(s) production: 4-ANPP*, phenethyl-4-ANPP*, Despropionyl para-fluorofentanyl (M) |
| 55 | 2022-08 | Pawtucket | Cotton | Fentanyl | Fentanyl* (O) Phenacetin (A) Acetylfentanyl (O) Cocaine (S) Starting material and/or byproducts in fentanyl(s) production: phenethyl-4-ANPP, 4-ANPP, benzylfentanyl (M) |
| 56 | 2022-08 | Pawtucket | Baggie (white powder) | Fentanyl | Fentanyl* (O) Cocaine* (S) Levamisole (A) Phenacetin (A) Acetylfentanyl (O) Starting material and/or byproducts in fentanyl(s) production: phenethyl-4-ANPP, 4-ANPP, norfentanyl (M) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine, ecgonine (M) |
| 57 | 2022-08 | Pawtucket | Baggie (brown powder) | Fentanyl | Fentanyl*(O) Xylazine* (A) Acetaminophen* (A) Acetylfentanyl (O) Cocaine (S) Parafluorofentanyl (O) Acrylfentanyl (O) Phenacetin (A) Fentanyl methyl carbamate (O) Starting material and/or byproducts in fentanyl(s) production: phenethyl-4-ANPP*, 4-ANPP*, despropionyl-para-fluorofentanyl, norfentanyl (M) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine (M) |
| 58 | 2022-08 | North Kingstown | Baggie (white powder) | Fentanyl | Fentanyl* (O) Caffeine (A) Para-fluorofentanyl (O) Delta-9-THC (C) Starting material and/or byproducts in fentanyl(s) production: phenethyl-4-ANPP, 4-ANPP |
| 59 | 2022-08 | North Kingstown | Straw (white powder) | Fentanyl | Fentanyl* (O) Para-fluorofentanyl (O) Acetylfentanyl (O) Xylazine (A) Caffeine (A) Delta-9-THC (C) Starting material and/or byproducts in fentanyl(s) production: phenethyl-4-ANPP, 4-ANPP, despropionyl-para-fluorofentanyl, norfentanyl, benzylfentanyl (M) |
| 60 | 2022-08 | Cumberland | White powder | Cocaine | Cocaine* (S) Levamisole (A) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine, ecgonine methyl ester (M) |
| 61 | 2022-08 | Providence | white powder | Carfentanil/ fentanyl | Fentanyl* (O) Xylazine* (A) Acetylfentanyl (O) Cocaine (S) Acetaminophen (A) Lidocaine (A) Acrylfentanyl (O) Starting material and/or byproducts in fentanyl(s) production: 4-ANPP, phenethyl-4-ANPP , Norfentanyl (M) |
| 62 | 2022-09 | Providence | White rock | Crack | Cocaine* (S) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine, ecgonine, ecgonine methyl ester, norcocaine, cocaethylene (M) |
| 63 | 2022-09 | Providence | Baggie (white powder) | Fentanyl | Xylazine* (A) Fentanyl* (O) Lidocaine (A) Acetaminophen (A) Acetylfentanyl (O) Cocaine (S) Acrylfentanyl (O) Starting material and/or byproducts in fentanyl(s) production: 4-ANPP, phenethyl-4-ANPP, Norfentanyl, Benzylfentanyl (M) |
| 64 | 2022-09 | Providence | Baggie (white poweder) | Cocaine | Cocaine* (S) Levamisole (A) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine, ecgonine, ecgonine methyl ester (M) |
| 65 | 2022-09 | Providence | Baggie (white powder) | Cocaine | Cocaine* (S) Trazadone (A) N,N-Dimethyltryptamine (DMT) (A) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine, ecgonine, ecgonine methyl ester, norcocaine (M) |
| 66 | 2022-09 | Providence | Baggie | Percocet | Fentanyl* (O) Cocaine (S) Xylazine (A) Starting material and/or byproducts in fentanyl(s) production: 4-ANPP, phenethyl-4-ANPP (M) |
| 67 | 2022-09 | Providence | Cooker (used prior to overdose reversed with naloxone) | Unknown | Fentanyl* (O) Para-fluorofentanyl* (O) Acetylfentanyl (O) Xylazine (A) Cocaine (S) Caffeine (A) Mepivacaine (A) Beta-hydroxyfentanyl (O) Para-bromofentanyl (O) 3 unknown substances likely fentanyl analogs Starting material and/or byproducts in fentanyl(s) production: 4-ANPP, phenethyl-4-ANPP, Despropionyl para-fluorofentanyl, Norfentanyl, Benzylfentanyl, N-methylnorfentanyl, NPP (M) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine (M) |
| 68 | 2022-09 | Providence | Pill (Blue 30) | Percocet | Fentanyl* (O) Para-fluorofentanyl (O) Beta-hydroxyfentanyl (O) Xylazine (A) Caffeine (A) Tramadol (O) Phenacetin (A) Acetylfentanyl (O) Cocaine (S) Levamisole (A) Acrylfentanyl (O) Starting material and/or byproducts in fentanyl(s) production: 4-ANPP, phenethyl-4-ANPP, Despropionyl para-fluorofentanyl, Norfentanyl (M) |
| 69 | 2022-09 | Providence | Cotton | Percocet | Fentanyl* (O) Xylazine* (A) Cocaine* (S) Acetylfentanyl (O) Para-fluorofentanyl (O) Delta-9-THC (C) Acrylfentanyl (O) Fentanyl methyl carbamate (O) Levamisole (A) Procaine (A) Acetaminophen (A) Caffeine (A) Lidocaine (A) Starting material and/or byproducts in fentanyl(s) production: phenethyl-4-ANPP*, NPP. 4-ANPP, Norfentanyl, n-methyl norfentanyl (M) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine, ecgonine, norcocaine (M) |
| 70 | 2022-09 | Providence | Baggie | Percocet | Fentanyl* (O) Xylazine* (A) Cocaine* (S) Acetylfentanyl (O) Lidocaine (A) Acrylfentanyl (O) Tramadol (O) MDMA (A) Butyrlfentanyl (O) Delta-9-THC (C) Caffeine (A) Phenacetin (A) Clonazepam (B) Oxycodone (O) Trazodone (A) Mepivacaine (A) Multiple unknown substances Starting material and/or byproducts in fentanyl(s) production: phenethyl-4-ANPP*, norfentanyl, N-methyl norfentanyl (M) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine, ecgonine, norcocaine (M) |
| 71 | 2022-09 | Providence | Baggie | Percocet | Xylazine* (A) Fentanyl* (O) Cocaine (S) Acetylfentanyl (O) Para-fluorofentanyl (O) Beta-hydroxyfentanyl (O) Acrylfentanyl (O) Acetaminophen (A) Delta-9THC (C) Procaine (A) Lidocaine (A) Mepivacaine (A) Starting material and/or byproducts in fentanyl(s) production: phenethyl-4-ANPP*, 4-ANPP, norfentanyl, n-methyl norfentanyl (M) |
| 72 | 2022-07 | Providence | Cooker (purple residue) | Fentanyl | Fentanyl* (O) Xylazine (A) Acetylfentanyl (O) Cocaine (S) Acetaminophen (A) Para-fluorofentanyl (O) Caffeine (A) Tramadol (O) Lidocaine (A) Phenacetin (A) Acrylfentanyl (O) Levamisole (A) Unknown substance (likely fentanyl analog) Starting material and/or byproducts in fentanyl(s) production: Phenethyl-4-ANPP, 4-ANPP,Norfentanyl, NPP (M) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine (M) |
| 73 | 2022-09 | Providence | Cooker | Fentanyl | Xylazine* (A) Fentanyl* (O) Cocaine (S) Delta-9-THC (C) Para-fluorofentanyl (O) Levamisole (A) Acetylfentanyl (O) Phenacetin (A) CBN (C) Caffeine (A) Lidocaine (A) Nicotine (A) Beta-hydroxyfentanyl (O) Mepivacaine (A) Para-bromofentanyl (O) 2-phenethylamine (S) Starting material and/or byproducts in fentanyl(s) production: Phenethyl-ANPP*, Norfentanyl, 4-ANPP, NPP, N-methyl-norfentanyl, Despropionyl para-fluorofentanyl (M) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine, Ecgonine, Norcocaine( M) |
| 74 | 2022-10 | Woonsocket | Baggie (white powder) | Fentanyl | Fentanyl* (O) Xylazine* (A) Cocaine (S) Acetylfentanyl (O) Starting material and/or byproducts in fentanyl(s) production: Phenethyl-4-ANPP, 4-ANPP, N-methyl norfentanyl (M) |
| 75 | 2022-10 | Woonsocket | Baggie (white pill) | Fentanyl | Fentanyl* (O) Xylazine (A) Para-fluorofentanyl (O) Phenacetin (A) Acetylfentanyl (O) Cocaine (S) Starting material and/or byproducts in fentanyl(s) production: Phenethyl-4-ANPP, 4-ANPP, Norfentanyl, Despropionyl Para-fluorofentanyl, Benzylfentanyl, 4-anilino-1-benzylpiperidine (M) |
| 76 | 2022-10 | Woonsocket | Baggie (white powder) | Fentanyl | Fentanyl* (O) Xylazine* (A) Cocaine (S) Lidocaine (A) Acetylfentanyl (O) Para-fluorofentanyl (O) Acrylfentanyl (O) Phentermine (S) Methamphetamine (S) Mepivacaine (A) Beta-hydroxyfentanyl (O) Levamisole (A) unknown substance Starting material and/or byproducts in fentanyl(s) production: Phenethyl-4-ANPP, 4-ANPP, n-methyl norfentanyl (M) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine(M) |
| 77 | 2022-11 | Providence | Cooker (white powder) | Unknown | Cocaine* (S) Delta-9-THC* (C) Fentanyl (O) Methadone (O) Procaine (A) Methamphetamine (S) Levamisole (A) Lidocaine (A) Starting material and/or byproducts in fentanyl(s) production: Phenethyl-4-ANPP, 4-ANPP(M) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine (M) |
| 78 | 2022-11 | Providence | Baggie (white rock) | Crack | Cocaine* (S) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine, Ecgonine methyl ester, Ecgonine, Cocaethylene, Norcocaine (M) |
| 79 | 2022-11 | East Greenwich | Pipe (black char) | Crack | Cocaine* (S) Levamisole (A) Phenacetin (A) Fentanyl (O) Nicotine (A) Methamphetamine (S) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine, Ecgonine methyl ester, Ecgonine, Cocaethylene, Norcocaine (M) |
| 80 | 2022-11 | Providence | Vial (white powder) | Ketamine | Ketamine* (H) Cocaine (S) |
| 81 | 2022-11 | Providence | Capsule with white powder | MDMA | MDMA* (H) MDDMA (H) Ketamine (H) Methamphetamine (S) Cocaine (S) N-N-dimethyltryptamine (H) MDA (H) |
| 82 | 2022-11 | Providence | Baggie | MDMA | MDMA* (H) Cocaine (S) MDDMA (H) Psilocin (H) Bufotenine (5-OH-DMT) (H) Hydroxyzine (A) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine (M) |
| 83 | 2022-11 | Providence | Baggie (white powder) | MDMA | MDMA* (H) Cocaine (S) Ketamine (H) MDDMA (H) Levamisole (A) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine (M) |
| 84 | 2022-11 | Woonsocket | Choy | Crack | Cocaine* (S) Levamisole (A) Methamphetamine (S) Lidocaine (A) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine*, Ecgonine methyl ester*, Ecgonine, Cocaethylene, Norcocaine (M) |
| 85 | 2022-11 | Woonsocket | Cooker | Methamphetamine | Cocaine* (S) Fentanyl (O) Ketamine (H) N-ethylamphetamine (S) Levamisole (A) Ephedrine (S) Methcathinone (S) Heroin (O) Unknown substance (likely stimulant) Pholedrine (S) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine, Ecgonine methyl ester, Ecgonine, Norcocaine (M) |
| 86 | 2022-11 | Providence | Pill (white) | Xanax | Bromazolam* (B) |
| 87 | 2022-11 | West Warwick | Baggie (white powder) | Fentanyl | Fentanyl* (O) Cocaine (S) Methamphetamine (S) Acetylfentanyl (O) Acrylfentanyl (O) Beta-hydroxyfentanyl (O) Starting material and/or byproducts in fentanyl(s) production: Phenethyl-4-ANPP,* 4-ANPP*, Norfentanyl (M) |
| 88 | 2022-11 | West Warwick | Baggie (white rock) | Crack | Cocaine* (S) Methamphetamine (S) Fentanyl N-ethylamphetamine Starting material and/or byproducts in fentanyl(s) production: Phenethyl-4-ANPP (M) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine, Ecgonine methyl ester, Ecgonine, Cocaethylene, Norcocaine (M) |
| 89 | 2022-11 | West Warwick | Baggie (white powder) | Fentanyl | Fentanyl* (O) Methamphetamine (S) Cocaine (S) Acetylfentanyl (O) Acrylfentanyl (O) Beta-hydroxyfentanyl (O) Levamisole (A) Butyrlfentanyl (O) Starting material and/or byproducts in fentanyl(s) production: Phenethyl-4-ANPP, 4-ANPP |
| 90 | 2022-11 | Providence | Baggie (white powder) | Ketamine | Ketamine* (H) Cocaine (S) Nicotinamide (A) MDMA (H) |
| 91 | 2022-12 | Providence | Pill (orange, round) | Adderall | Methamphetamine* (S) Caffeine (A) Cocaine (S) Etizolam (B) |
| 92 | 2022-12 | Providence | Bubble pipe (white crystal) | Uknown | Methamphetamine* (S) Amphetamine (S) Cocaine (S) N-ethylamphetamine (S) 4-ethylamphetamine (S) |
| 93 | 2022-12 | Providence | Syringe | Unknown | Fentanyl* (O) Acetylfentanyl (O) Xylazine (A) Caffeine (A) Acetaminophen (A) Methamphetamine (S) Cocaine (S) Beta-hydroxyfentanyl (O) Para-fluoro valeryl fentanyl (O) 4 unknown substances (likely fentanyl analogs) Starting material and/or byproducts in fentanyl(s) production: Phenethyl-4-ANPP, 4-ANPP, NPP, benzylfentanyl, 4-anilino-1-benzylpipieridine, 4-anilinopiperidine (M) |
| 94 | 2022-12 | Providence | Syringe | Unknown | Fentanyl* (O) Xylazine* (A) Acetylfentanyl* (O) Caffeine* (A) Para-fluorofentanyl (O) Methamphetamine (S) Cocaine (S) Phenacetin (S) Acrylfentanyl (O) Beta-hydroxyfentanyl (O) Starting material and/or byproducts in fentanyl(s) production: Phenethyl-4-ANPP*, 4-ANPP, Despropionyl-para-fluorofentanyl, norfentanyl, acetyl-norfentanyl, NPP, 4-anilinopiperidine (M) |
| 95 | 2022-12 | Providence | Syringe | Uknown | Fentanyl* (O) Xylazine* (A) Tramadol (O) Acetylfentanyl (O) Methamphetamine (S) Ketamine (H) Caffeine (A) Para-fluorofentanyl (O) Cocaine (S) Acrylfentanyl (O) Beta-hydroxyfentanyl (O) Starting material and/or byproducts in fentanyl(s) production: 4-ANPP*, Phenethyl-4-ANPP, norfentanyl, n-methyl norfentanyl, NPP(M) |
| 96 | 2022-12 | Providence | Plastic mechanical pencil (white powder) | Fentanyl | Fentanyl*(O) Para-fluorofentanyl (O) Tramadol (O) Xylazine (A) Acetylfentanyl (O) Phenylfentanyl (O) Acrylfentanyl (O) Para-fluoroacetyl fentanyl (O) O-desmethyltramadol (O) Methamphetamine (S) Lidocaine (A) Melatonin (A) 2-phenethylamine (S) Starting material and/or byproducts in fentanyl(s) production: Phenethyl-4-ANPP, despropionyl para-fluorofentanyl, norfentanyl, n-methyl norfentanyl, ANPP, 4-anilinopiperidine (M) |
| 97 | 2022-12 | Providence | Baggie (crystal) | Crystal meth | Methamphetamine*(S) Amphetamine* (S) Fentanyl*(O) N-ethylamphetamine (S) Cocaine(S) Methcathinone (S) Para-fluorofentanyl (O) Pholedrine (S) Tramadol (O) 4-ethylamphetamine (S) Starting material and/or byproducts in fentanyl(s) production: Phenethyl-4-ANPP, 4-ANPP (M) |
| 98 | 2022-12 | Providence | Baggie (orange crystal/powder) | Fentanyl | Fentanyl*(O) Methamphetamine*(S) Cocaine(S) Para-fluorofentanyl (O) Tramadol (O) Nicotinamide (A) Capsaicin (A) Starting material and/or byproducts in fentanyl(s) production: Phenethyl-4-ANPP, 4-ANPP (M) |
| 99 | 2022-12 | Providence | Aluminum foil (white powder) | Fentanyl | Fentanyl*(O) Tramadol* (O) Para-fluorofentanyl (O) Methamphetamine (S) Xylazine (A) Acetylfentanyl (O) Lidocaine (A) Acrylfentanyl (O) O-desmethyltramadol (O) Beta-hydroxyfentanyl (O) Melatonin (A) Starting material and/or byproducts in fentanyl(s) production: Phenethyl-4-ANPP, 4-ANPP, norfentanyl (M) |
| 100 | 2022-12 | Providence | Aluminum foil (black char) | Fentanyl | Fentanyl*(O) Tramadol* (O) Para-fluorofentanyl (O) Methamphetamine (S) Xylazine (A) Acetylfentanyl (O) Lidocaine (A) Acrylfentanyl (O) Melatonin (A) Starting material and/or byproducts in fentanyl(s) production: Phenethyl-4-ANPP*, 4-ANPP*, norfentanyl, despropionyl para-fluorofentanyl (M) |
| 101 | 2022-12 | Providence | Aluminum foil (black char) | Fentanyl | Fentanyl*(O) Methamphetamine (S) Para-fluorofentanyl (O) Cocaine (S) Tramadol (O) Starting material and/or byproducts in fentanyl(s) production: Phenethyl-4-ANPP, 4-ANPP(M) |
| 102 | 2022-12 | Providence | Pipe stem | Unknown | Cocaine* (S) Lidocaine (A) Phenacetin (A) Acetaminophen (A) Levamisole (A) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine*, Ecgonine methyl ester*, Ecgonine, Cocaethylene (M) |
| 103 | 2022-12 | Providence | Choy (black residue) | Unknown | Cocaine* (S) Levamisole* (A) Fentanyl (O) Aminorex (A) Diphenhdyramine (A) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine*, Ecgonine methyl ester*, Ecgonine, Cocaethylene, Norcocaine (M) |
| 104 | 2023-01 | Providence | Brown powder | Heroin/Dope | Fentanyl* (O) Para-fluorofentanyl* (O) Xylazine* (A) Cocaine* (S) Tramadol* (O) Procaine (A) Lidocaine (A) Levamisole (A) Acetaminophen (A) Caffeine (A) Methamphetamine (S) Acetylfentanyl (O) Isotonitazene (O) Quinidine (A) Heroin (O) Phenacetin (A) Beta-hydroxyfentanyl (O) Para-fluoroacetylfentanyl (O) O-desmethyltramadol (O) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine, Ecgonine methyl ester, Norcocaine (M) Starting material and/or byproducts in fentanyl(s) production: 4-ANPP*, Phenethyl-4-ANPP*, Despropionyl para-fluorofentanyl, Norfentanyl, Benzylfentanyl, 4-anilino-1-benzylpipieridine(M) |
| 105 | 2023-01 | Providence | White pill in blister pack | Xanax | Alprazolam* (B) |
| 106 | 2023-01 | Providence | Pill fragment white pill with "x" | Xanax | Etizolam* (B) Flualprazolam* (B) Ketamine (A) Desalkylflurazepam (B) Lidocaine (A) Clonazolam (B) |
| 107 | 2023-01 | Providence | Bag white crystals | Crystal meth | Methamphetamine* (S) |
| 108 | 2023-01 | Providence | White pill with "x" | Klonopin | Clonazepam* (B) Methamphetamine (S) |
| 109 | 2023-01 | Providence | Pill fragment white pill with "x" | Xanax | Etizolam* (B) |
| 110 | 2023-01 | Providence | Light blue pill no marking | Xanax | Alprazolam* (B) |
| 111 | 2023-01 | Providence | Baggie (pilll powder orange) | Adderall 30 | Methamphetamine* (S) Ketamine (A) Cocaine (S) |
| 112 | 2023-01 | Providence | Baggie (crushed pill powder white) | Oxycodone | Oxycodone* (O) Hydrocodone (O) Methamphetamine (S) |
| 113 | 2023-01 | Providence | Baggie (off white crystal, salt-like) | Ketamine | Ketamine* (H) |
| 114 | 2023-01 | Providence | Pill fragment light blue | Xanax | Etizolam* (B) Clonazolam* (B) Clonazepam (B) Ketamine (H) |
| 115 | 2023-01 | Providence | Baggie (white powder) | Cocaine | Cocaine* (S) Ketamine (H) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine*, Ecgonine methyl ester*, Ecgonine, Cocaethylene (M) |
| 116 | 2023-01 | Providence | Pill light blue no marking | Xanax | Bromazolam* (B) Flubromazolam (B) Alprazolam (B) |
| 117 | 2023-01 | Providence | Baggie (white crystal, salt-like) | Ketamine | Ketamine* (H) Norketamine (H) |
| 118 | 2023-01 | Providence | Baggie (light pink powder) | Cocaine | Cocaine* (S) Levamisole (A) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine*, Ecgonine methyl ester*, Ecgonine, Norcocaine (M) |
| 119 | 2023-01 | East Greenwich | Syringe cap (crystal) | Crystal meth | Cocaine* (S) Methamphetamine* (S) Fentanyl* (O) Xylazine (A) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine (M) Starting material and/or byproducts in fentanyl(s) production: Phenethyl-4-ANPP*, 4-ANPP(M) |
| 120 | 2023-01 | East Greenwich | Syringe cap (crystal) | Crystal meth | Cocaine* (S) Methamphetamine (S) Fentanyl (O) N-ethylamphetamine (S) Xylazine (A) Ketamine (H) Levamisole (A) 4-ethylamphetamine (S) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine, Ecgonine methyl ester, Cocaethylene(M) Starting material and/or byproducts in fentanyl(s) production: Phenethyl-4-ANPP*, 4-ANPP(M) |
| 121 | 2023-01 | East Greenwich | Syringe cap (crystal) | Crystal meth | Fentanyl* (O) Xylazine* (A) Methamphetamine* (S) Cocaine* (S) Acetylfentanyl (O) Para-fluorofentanyl (O) Phenacetin (A) Acrylfentanyl (O) Procaine (A) Butylfentanyl (O) Levamisole (A) Lidocaine (A) Beta-hydroxyfentanyl (O) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine (M) Starting material and/or byproducts in fentanyl(s) production: Phenethyl-4-ANPP*, 4-ANPP, Despropionyl-para-fluorofentanyl, norfentanyl, 4-anilinopiperidine (M) |
| 122 | 2023-01 | West Warwick | Baggie (white powder) | Fentanyl | Fentanyl* (O) Acetylfentanyl (O) Cocaine (S) Acrylfentnayl (O) Methamphetamine (S) Xylazine (A) Butylfentanyl (O) Beta-hydroxyfentanyl (O) Starting material and/or byproducts in fentanyl(s) production: Phenethyl-4-ANPP, 4-ANPP, norfentanyl, 4-anilinopiperidine, 4-anilino-1-boc-piperidine (M) |
| 123 | 2023-01 | West Warwick | Baggie (crystals) | Crystal meth | Methamphetamine* (S) Cocaine (S) N-ethylamphetamine (S) Fentanyl (O) Para-fluorofentanyl (O) 4-ethylamphetamine (S) |
| 124 | 2023-02 | Providence | syringe (white crystal) | Crystal meth | Methamphetamine* (S) Cocaine* (S) Delta-9-THC (C) Phenacetin (A) N-ethylamphetamine (S) Pholedrine (S) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine, Norcocaine (M) |
| 125 | 2023-02 | Providence | syringe | Fentanyl | Fentanyl* (O) Beta-hydroxyfentanyl* (O) Cocaine (S) Methamphetamine (S) Acetylfentanyl (O) Xylazine (A) Acrylfentanyl (O) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine, Ecgonine methyl ester, Ecgonine, Norcocaine (M) Starting material and/or byproducts in fentanyl(s) production: Phenethyl-4-ANPP, 4-ANPP, Norfentanyl, (M) |
| 126 | 2023-02 | Providencee | Pill fragment (white with x) | Xanax | Clonazolam* (B) |
| 127 | 2023-02 | Providence | White powder | Fentanyl | Fentanyl* (O) Acetylfentanyl (O) Butyrylfentanyl (O) Acrylfentanyl (O) Starting material and/or byproducts in fentanyl(s) production: 4-ANPP, phenethyl-4-ANPP, NPP, 4-anilinopiperidine (M) |
| 128 | 2023-02 | Providence | White power | Fentanyl | Fentanyl* (O) Xylazine (A) Lidocaine (A) Acetylfentanyl (O) Methamphetamine (S) Cocaine (S) Quinine (A) Butyrylfentanyl (O) Acrylfentanyl (O) Protonitazene (O) N-ethylamphetamine (S) Noscapine (A) Starting material and/or byproducts in fentanyl(s) production: 4-ANPP, Phenethyl-4-ANPP, norfentanyl(M) |
| 129 | 2023-02 | Providence | White residue | Fentanyl | Fentanyl* (O) Acetylfentanyl (O) Promethazine (A) Cocaine (S) Para-fluorofentanyl (O) Xylazine (A) Methamphetamine (S) Acrylfentanyl (O) Phenacetin (A) Lidocaine (A) Quinine (A) Delta-9-THC (C) N-ethylamphetamine (S) Hydroxyzine (A) Beta-hydroxyfentanyl (O) Starting material and/or byproducts in fentanyl(s) production: 4-ANPP, norfentanyl, NPP, 4-anilinopiperidine, N-methyl norfentanyl (M) |
| 130 | 2023-02 | Woonsocket | Baggie (white powder) | Fentanyl | Fentanyl* (O) Acetylfentanyl (O) Cocaine (S) Beta-hydroxyfentanyl (O) Starting material and/or byproducts in fentanyl(s) production: Phenethyl-4-ANPP*, 4-ANPP*, norfentanyl (M) |
| 131 | 2023-02 | Woonsocket | Baggie (white powder) | Cocaine | Cocaine* (S) Caffeine (A) Levamisole (A) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine, Ecgonine methyl ester, Ecgonine, Norcocaine, Cocaethylene (M) |
| 132 | 2023-02 | Providence | Baggie (white residue) | Unknown | Fentanyl* (O) Cocaine (S) Para-fluorofentanyl (O) Acetylfentanyl (O) Lidocaine (A) Beta-hydroxyfentanyl (O) Starting material and/or byproducts in fentanyl(s) production: Phenethyl-4-ANPP, 4-ANPP, norfentanyl, 4-anilinopiperidine(M) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine, Ecgonine, Norcocaine (M) |
| 133 | 2023-02 | Providence | Cotton (periwinkle) | Fentanyl | Fentanyl* (O) Para-fluorofentanyl (O) Acetylfentanyl (O) Caffeine (A) Levamisole (A) Tramadol (O) Xylazine (A) Heroin (O) Procaine (A) Lidocaine (A) 6-Acetylmorphine (O) Cocaine (S) Phenacetin (A) Quinine (A) Butyrylfentanyl (O) Beta-hydroxyfentanyl (O) 6- Acetylcodeine (O) O-desmethyltramadol (O) Methamphetamine (S) Acrylfentanyl (O) Beta-hydroxyfentanyl (O) Noscapine (A) Starting material and/or byproducts in fentanyl(s) production: Phenethyl-4-ANPP*, 4-ANPP*, Norfentanyl, NPP, 4-anilinopiperidine, 4-anilino-1-boc-piperidine, Despropionyl para-fluorofentanyl (M) |
| 134 | 2023-02 | Providence | Cotton (perwinkle) | Fentanyl | Fentanyl* (O) Para-fluorofentanyl (O) Caffeine (A) Acetylfentanyl (O) Levamisole (A) Tramadol (O) Heroin (O) Xylazine (A) Lidocaine (A) Procaine (A) Cocaine (S) 6-Acetylmorphine (O) Quinine (A) Phenacetin (A) 6-Acetylcodeine (O) Butyrylfentanyl (O) Acrylfentanyl (O) Papaverine (A) O-desmethyltramadol (O) Acetaminophen (A) Morphine (O) Beta-hydroxyfentanyl (O) Methamphetamine (S) Starting material and/or byproducts in fentanyl(s) production: Phenethyl-4-ANPP, 4-ANPP, Norfentanyl, NPP, Benzylfentanyl 4-anilinopiperidine, 4-anilino-1-boc-piperidine,Despropionyl para-fluorofentanyl (M) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine (M) |
| 135 | 2023-02 | Providence | Baggie (white powder) | Fentanyl | Fentanyl* (O) Cocaine (S) Acetylfentanyl (O) Para-fluorofentanyl (O) Xylazine (A) Levamisole (A) Acrylfentanyl (O) Lidocaine (A) Beta-hydroxyfentanyl (O) Starting material and/or byproducts in fentanyl(s) production: Phenethyl-4-ANPP*, 4-ANPP*, Norfentanyl, Despropionyl para-fluorofentanyl 4-anilinopiperidine, 4-anilino-1-boc-piperidine(M) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine (M) |
| 136 | 2023-02 | Warwick | Baggie (white powder) | Fentanyl | Fentanyl* (O) Xylazine* (A) Para-fluorofentanyl* (O) Cocaine* (S) Acetylfentanyl (O) Phenacetin (A) Levamisole (A) Nicotine (A) Lidocaine (A) Para-fluoroacetylfentanyl (O) Acrylfentanyl (O) Methamphetamine (S) Beta-hydroxyfentanyl (O) Starting material and/or byproducts in fentanyl(s) production: Phenethyl-4-ANPP*, 4-ANPP, Norfentanyl, Despropionyl para-fluorofentanyl 4-anilinopiperidine, N-methyl norfentanyl (M) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine, Norcocaine (M) |
| 137 | 2023-02 | Warwick | Baggie (white powder) | Crack | Cocaine* (S) Phenacetin (A) Levamisole (A) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine, Ecgonine methyl ester, Ecgonine, Norcocaine, Cocaethylene (M) |
| 138 | 2023-02 | Warwick | Baggie (white powder) | Crack | Cocaine* (S) Delta-9-THC (C) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine, Ecgonine methyl ester, Ecgonine, Norcocaine (M) |
| 139 | 2023-03 | Providence | Paper wrapped powder | Fentanyl | Fentanyl* (O) Cocaine (S) Para-fluorofentanyl (O) Xylazine (A) Acetylfentanyl (O) Methamphetamine (S) Acrylfentanyl (O) Caffeine (A) Beta-hydroxyfentanyl (O) Starting material and/or byproducts in fentanyl(s) production: Phenethyl-4-ANPP, 4-ANPP, Norfentanyl, Despropionyl para-fluorofentanyl (M) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine (M) |
| 140 | 2023-03 | Providence | Baggie (white powder) | Fentanyl | Fentanyl* (O) Xylazine (A) Cocaine (S) Acetylfentanyl (O) Quinine (A) Para-fluorofentanyl (O) Methamphetamine (S) Caffeine (A) Buyrylfentanyl (O) Beta-hydroxyfentanyl (O) Starting material and/or byproducts in fentanyl(s) production: Phenethyl-4-ANPP, 4-ANPP, Norfentanyl, n-methyl nofentanyl (M) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine (M) |
| 141 | 2023-03 | Providence | Pill (off white numbered 54262) | Morphine | Hydromorphone* (O) Morphine* (O) Codeine (O) |
| 142 | 2023-03 | Providence | Powder (white) | Ketamine | Ketamine* (H) |
| 143 | 2023-03 | Providence | Crystal (clear) | MDMA | MDMA* (H) MDDMA (H) Ketamine (H) Cocaine (S) Methamphetamine (S) |
| 144 | 2023-03 | Warwick | Meth pipe (black residue) | Crystal Meth | Methamphetamine (S)* Amphetamine (S) N-ethylamphetamine (S) Cocaine (S) Methcathinone (S) Fentanyl (O) Pholedrine (S) N-propylamphetamine (S) |
| 145 | 2023-04 | Providence | Glove tip (crystal) | Crystal meth | Methamphetamine (S)* Cocaine (S) N-ethylamphetamine (S) Amphetamine (S) |
| 146 | 2023-04 | Providence | Syringe (blood) | Unknown | Cocaine* (S) Fentanyl* (O) N-ethylamphetamine (S) Xylazine (A) Para-fluorofentanyl (O) Sildenafil (A) Unknown amphetamine (S) Sulfamethoxazole (A) N-propylamphetamine (S) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine,* Ecgonine methyl ester, Ecgonine (M) Starting material and/or byproducts in fentanyl(s) production: Phenethyl-4-ANPP, 4-ANPP (M) |
| 147 | 2023-04 | Providence | white powder | Fentanyl with xylazine | Fentanyl* (O) Acetylfentanyl (O) Buyrylfentanyl (O) Acrylfentanyl (O) Cocaine (S) Xylazine (A) Starting material and/or byproducts in fentanyl(s) production: Phenethyl-4-ANPP, 4-ANPP, Norfentanyl, 4-anilinopiperidine (M) |
| 148 | 2023-04 | Warwick | Pipe (mixed residue) | Crystal meth | Methamphetamine (S)* N-ethylamphetamine (S) Amphetamine (S) Cocaine (S) Methcathinone (S) Pholedrine (S) N-propylamphetamine (S) |
| 149 | 2023-04 | Warwick | Pipe (white cloudy and crystal residue) | Crystal meth | Methamphetamine (S)* Cocaine (S) Amphetamine (S) N-ethylamphetamine (S) Methcathinone (S) Pholedrine (S) N-propylamphetamine (S) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine, Norcocaine, Ecgonine methyl ester (M) |
| 150 | 2023-05 | Providence | Aluminum foil | Fentanyl | Fentanyl* (O) Acetylfentanyl (O) Starting material and/or byproducts in fentanyl(s) production: Phenethyl-4-ANPP, 4-ANPP(M) |
| 151 | 2023-05 | Newport | Baggie (white crystal) | Crystal meth | Methamphetamine (S)* N-ethylamphetamine (S) |
| 152 | 2023-05 | Providence | Cotton (purple powder) | Fentanyl | Fentanyl* (O) Xylazine* (A) Acetylfentanyl* (O) Caffeine* (A) Acetaminophen (A) Cocaine (S) Para-fluorofentanyl (O) Acrylfentany (O) Levaminsole (A) Starting material and/or byproducts in fentanyl(s) production: Phenethyl-4ANPP, 4-ANPP, NPP, 4-anilinopiperidine, Norfentanyl (M) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine (M) |
| 153 | 2023-05 | Warwick | Baggie (white powder) | MDMA | Cocaine (S)* Pyridoxine (A) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine, Ecgonine (M) |
| 154 | 2023-05 | Warwick | Baggie | Crack | Cocaine (S)* Fentanyl (O) Levamisole (A) Buprenorphine (O) Xylazine (A) Caffeine (A) Theobromine (A) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine*, Ecgonine methyl ester, Ecgonine, Cocaethylene, Norcocaine(M) Starting material and/or byproducts in fentanyl(s) production: Phenethyl-4-ANPP, 4-ANPP |
| 155 | 2023-05 | Woonsocket | Baggie (powder greenish hue) | MDMA | Dextromethorphan (H)* Cocaine (S)* Methamphetamine (S) Fentanyl (O) Acetylfentanyl (O) Dextrorphan (H) Acetaminophen (A) Xylazine (A) Metonitazene (O) Isotonitazene (O) Levamisole (A) Noscapine (A) Lidocaine (A) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine, Norcocaine, Ecgonine, Ecgonine methyl ester (M) Starting material and/or byproducts in fentanyl(s) production: 4-ANPP, 4-anilinopiperidine, phenethyl-4ANPP (M) |
| 156 | 2023-06 | Providence | White powder | Fentanyl | Fentanyl* (O) Acetylfentanyl (O) Cocaine (S) Starting material and/or byproducts in fentanyl(s) production: 4-ANPP, phenethyl-4ANPP (M) |
| 157 | 2023-06 | Providence | White powder | Fentanyl | Xylazine* (A) Fentanyl* (O) Acetaminophen (A) Acetylfentanyl (O) Caffeine (A) Starting material and/or byproducts in fentanyl(s) production: 4-ANPP, 4-anilinopiperidine, phenethyl-4ANPP (M) |
| 158 | 2023-06 | Providence | Clear white crystals | Crystal meth | Methamphetamine (S)* |
| 159 | 2023-06 | Providence | Orange Pill (Adderall 30) | Adderall | Methamphetamine (S)* |
| 160 | 2023-06 | Internet purchase / Providence | Light blue pill | Morphine | Morphine (O)* Ketamine (H) Codeine (O) Heroin (O) |
| 161 | 2023-06 | Internet purchase / Providence | Clear pill capsule with black residue (Suspect high likelihood of cross-contamination with sample 162) | Heroin | Heroin* (O) 6-acetylmorphine (O) 6-acetylcodeine (O) Papaverine (A) Bromazolam (B) Clonazolam (B) Codeine (O) Metonitazene (O) Diphenhydramine (A) Protonitazene (O) Starting material and/or byproducts in fentanyl(s) production: phenethyl-4ANPP (M) |
| 162 | 2023-06 | Internet purchase / Providence | Greyish white powder on tin foil (Suspect high likelihood of cross-contamination with sample 161) | Heroin | Metonitazene* (O) Protonitazene* (O) Bromazolam* (B) Diphenhydramine* (A) Quinidine* (A) Clonazolam* (B) Parafluorofentanyl (O) Fentanyl (O) Heroin (O) 6-monoacetylmorphine (O) 6-monoacetylcodeine (O) Xylazine (A) Etonitazene (O) Clonazepam (B) Starting material and/or byproducts in fentanyl(s) production: Phenethyl-4ANPP, despropionyl para-fluorofentanyl, 4-anilinopiperidine, 4-ANPP (M) |
| 163 | 2023-07 | Providence | White powder | Fentanyl | Fentanyl* (O) Xylazine (A) Caffeine (A) Butyrlfentanyl (O) Acetylfentanyl (O) Cocaine (S) Methamphetamine (S) Starting material and/or byproducts in fentanyl(s) production: 4-ANPP, phenethyl-4ANPP (M) |
| 164 | 2023-07 | West Warwick | Rock (off white) | Crack cocaine | Cocaine* (S) Levamisole (A) Benzocaine (A) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine, Ecgonine methyl ester, Ecgonine, Norcocaine, Cocaethylene (M) |
| 165 | 2023-07 | Providence | White powder | Fentanyl | Fentanyl* (O) Acetylfentanyl (O) Cocaine (S) Xylazine (A) Acetaminophen (A) Caffeine (A) Acrylfentanyl (O) Starting material and/or byproducts in fentanyl(s) production: 4-ANPP, phenethyl-4ANPP, Norfentanyl, 4-anilinopiperidine (M) |
| 166 | 2023-07 | West Warwick | Baggie (Purple powder) | Fentanyl | Fentanyl* (O) Acetylfentanyl (O) Cocaine (S) Butyrlfentanyl (O) Acrylfentanyl (O) Valerylfentanyl (O) Starting material and/or byproducts in fentanyl(s) production: 4-ANPP, phenethyl-4ANPP, Norfentanyl, N-methyl-norfentanyl, 4-anilinopiperidine (M) |
| 167 | 2023-07 | Providence | Cotton (Brown) | Fentanyl | Fentanyl* (O) Protonitazene (O) Cocaine (S) Xylazine (A) Methamphetamine (S) Caffeine (A) Lidocaine (A) Tramadol (O) Acetylfentanyl (O) Gabapentin (A) Metonitazene (O) Unknown (O) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine Starting material and/or byproducts in fentanyl(s) production: 4-ANPP*, phenethyl-4ANPP*, Norfentanyl(M) |
| 168 | 2023-07 | Providence | Powder (yellow/white) | Fentanyl | Fentanyl* (O) Acetylfentanyl (O) Starting material and/or byproducts in fentanyl(s) production: 4-ANPP*, Norfentanyl, 4-anilinopiperidine (M) |
| 169 | 2023-08 | Providence | Cotton in cooker | Fentanyl | Fentanyl* (O) Acetylfentanyl (O) Lidocaine (A) Xylazine (A) Tramadol (O) Para-fluorofentanyl (O) Cocaine (S) Beta-hydroxyfentanyl (O) Starting material and/or byproducts in fentanyl(s) production: Phenethyl-4ANPP*, Norfentanyl, 4-anilinopiperidine, 4-anilino-1-boc-piperidine (M) |
| 170 | 2023-08 | Internet purchase / Providence | Blue Pill (200 mg marking) | Morphine | Morphine* (O) Codeine (O) MDMA (H) Fentanyl (O) Starting material and/or byproducts in fentanyl(s) production: 4-ANPP (M) |
| 171 | 2023-08 | Internet purchase / Providence | White powder | Heroin | Heroin* (O) 6-monoacetylcodeine (O) 6-monoacetylmorphine (O) Para-fluorofentanyl (O) Fentanyl (O) Papaverine (A) Codeine (O) Acetylfentanyl (O) Oxycodone (O) Starting material and/or byproducts in fentanyl(s) production: Phenethyl-4ANPP, despropionyl para-fluorofentanyl, 4-ANPP (M) |
| 172 | 2023-08 | Internet purchase / Providence | Baggie (brown residue) | Tar Heroin | Heroin* (O) Papaverine (A) 6-monoacetylcodeine (O) 6-monoacetylmorphine (O) Noscapine (A) Cocaine (S) Ketamine (H) Methamphetamine (S) |
| 173 | 2023-08 | Internet purchase / Providence | Tar (black and brown) | Tar Heroin | Heroin* (O) Fentanyl* (O) Papaverine (A) 6-monoacetylcodeine (O) Noscapine (A) 6-monoacetylmorphine (O) Codeine (O) Cocaine (S) Xylazine (A) Starting material and/or byproducts in fentanyl(s) production: Benzylfentanyl |
| 174 | 2023-08 | Internet purchase / Providence | Capsule with light brown residue | Tar Heroin | Heroin* (O) Papaverine (A) Codeine (O) 6-monoacetylcodeine (O) 6-monoacetylmorphine (O) |
| 175 | 2023-08 | Providence | Rubber glove | Fentanyl | Xylazine* (A) Fentanyl* (O) Acetylfentanyl (O) Beta-hydroxyfentanyl (O) Carisoprodol (A) Starting material and/or byproducts in fentanyl(s) production: Phenethyl-4ANPP*, 4-anilinopiperidine, 4-ANPP, n-methyl-norfentanyl (M) |
| 176 | 2023-08 | Providence | Cooker (black flecks) | Methamphetamine | Methamphetamine (S)* Cocaine (S) Fentanyl (O) Xylazine (A) Starting material and/or byproducts in fentanyl(s) production: 4-ANPP (M) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine (M) |
| 177 | 2023-08 | Providence | Pipe (brown crystal) | Crystal meth | Methamphetamine (S)* Fentanyl (O) Pholedrine (S) N-ethylamphetamine (S) Ephedrine (S) Methcathinone (S) Acetylfentanyl (S) N-propylamphetamine (S) Starting material and/or byproducts in fentanyl(s) production: 4-ANPP, Phenethyl-4ANPP (M) |
| 178 | 2023-08 | Providence | White powder | Fentanyl | Fentanyl* (O) Acetylfentanyl (O) Beta-hydroxyfentanyl (O) Starting material and/or byproducts in fentanyl(s) production: 4-ANPP*, Phenethyl-4ANPP, 4-anilinopiperidine (M) |
| 179 | 2023-08 | Providence | Cooker (white powder) | Fentanyl | Fentanyl* (O) Methamphetamine (S)* Acetylfentanyl (O) Acrylfentanyl (O) Beta-hydroxyfentanyl (O) Starting material and/or byproducts in fentanyl(s) production: 4-ANPP*, Phenethyl-4ANPP, 4-anilinopiperidine |
| 180 | 2023-08 | Providence | Pipe (white powder, black char) | Crystal meth | Methamphetamine (S)* Cocaine (S) Fentanyl (O) Amphetamine (S) Gabapentin (A) N-ethylamphetamine (S) N-propylamphetamine (S) Pholedrine (S) Starting material and/or byproducts in fentanyl(s) production: 4-ANPP, Phenethyl-4ANPP (M) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine, Norcocaine, Ecgonine methyl ester (M) |
| 181 | 2023-09 | Providence | crystal (white) | Crystal meth | Methamphetamine (S)* |
| 182 | 2023-09 | Providence | powder (tan) | Heroin | Xylazine* (A) Fentanyl* (O) Starting material and/or byproducts in fentanyl(s) production: 4-ANPP, Phenethyl-4ANPP, 4-anilinopiperidine (M) |
| 183 | 2023-10 | Providence | White powder | Fentanyl without xylazine | Fentanyl* (O) Starting material and/or byproducts in fentanyl(s) production: 4-ANPP*, Phenethyl-4ANPP, norfentanyl |
| 184 | 2023-10 | Providence | Baggie (off white powder) | Fentanyl with xylazine | Fentanyl* (O) Caffeine (A) Xylazine (A) Cocaine (S) Lidocaine (A) Caffeine (A) Acetylfentanyl (O) Methamphetamine (S) Protonitazene (O) Metonitazene (O) Starting material and/or byproducts in fentanyl(s) production: 4-ANPP*, Phenethyl-4ANPP, norfentanyl, 4-anilinopiperidine |
| 185 | 2023-10 | Providence | White powder | Fentanyl | Fentanyl* (O) Acetylfentanyl (O) Acrylfentanyl (O) Starting material and/or byproducts in fentanyl(s) production: 4-ANPP*, Phenethyl-4ANPP, norfentanyl, 4-anilinopiperidine |
| 186 | 2023-10 | Providence | Pill (light blue) | Percocet | Fentanyl* (O) Trazadone (A) Para-fluorofentanyl (O) Acetylfentanyl (O) Diphenhydramine (A) Acetaminophen (A) Starting material and/or byproducts in fentanyl(s) production: 4-ANPP*, Phenethyl-4ANPP, norfentanyl, 4-anilinopiperidine |
| 187 | 2023-10 | Providence | syringe | unknown | Fentanyl* (O) Caffeine (A) Acetylfentanyl (O) Beta-hydroxyfentanyl (O) Starting material and/or byproducts in fentanyl(s) production: 4-ANPP, Phenethyl-4ANPP (M) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine (M) |
| 188 | 2023-10 | Providence | syringe | unknown | Cocaine* (S) Fentanyl (O) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine (M) |
| 189 | 2023-10 | Providence | pipe | unknown | Cocaine* (S) Levamisole (A) Fentanyl (O) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine, norcocaine (M) |
| 190 | 2023-11 | Providence | pipe | Crack | Cocaine* (S) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine, norcocaine (M) |
| 191 | 2023-11 | Providence | cooker with cotton | Unknown | Fentanyl* (O) Lidocaine (A) Parafluorofentanyl (O) Cocaine (S) Acetaminophen (A) Bromazolam (B) Tramadol (O) Phenacetin (A) Isotonitazene (O) Caffeine (A) Carfentanil (O) Diphenhydramine (O) Delta-9-THC (C) Caffeine (A) Beta-hydroxyfentanyl (O) Papaverine (A) Xylazine (A) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine (M) Starting material and/or byproducts in fentanyl(s) production: 4-ANPP, Phenethyl-4ANPP*, norfentanyl, 4-anilino-1-boc-piperidine, despropionyl para-fluorofentanyl (M) |
| 192 | 2023-12 | Providence | cooker (purple powder) | Unknown | Xylazine* (A) Fentanyl* (O) Caffeine (A) Acetylfentanyl (O) Beta-hydroxyfentanyl (O) Acetaminophen (A) Starting material and/or byproducts in fentanyl(s) production: 4-ANPP, Phenethyl-4ANPP, 4-anilinopiperidine (M) |
| 193 | 2023-12 | Providence | cotton (purple powder) | Unknown | Xylazine* (A) Fentanyl* (O) Cocaine (S) Phenacetin (A) Acetylfentanyl (O) Beta-hydroxyfentanyl (O) Methamphetamine (S) Hydroxyzine (A) Starting material and/or byproducts in fentanyl(s) production: 4-ANPP, Phenethyl-4ANPP, 4-anilinopiperidine, N-methyl norfentanyl(M) |
| 194 | 2023-12 | Providence | Cooker plus cotton (white powder) | Unknown | Cocaine* (S) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine, norcocaine, ecgonine methyl ester, ecgonine, cocaethylene (M) |
| 195 | 2023-12 | Providence | Cooker plus cotton (white powder) | Unknown | Cocaine* (S) Fentanyl (O) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine, norcocaine, ecgonine methyl ester (M) |
| 196 | 2023-12 | Providence | Cooker (white powder) | Uknown | Cocaine* (S) Lidocaine (A) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine, norcocaine, ecgonine methyl ester (M) |
| 197 | 2023-12 | Providence | Cooker plus cotton (white and purple powder) | Unknown | Fentanyl* (O) Xylazine* (A) Phenacetin* (A) Cocaine (S) Caffeine (A) Quinine (A) Acetylfentanyl (O) Starting material and/or byproducts in fentanyl(s) production: 4-ANPP*, Phenethyl-4ANPP, 4-anilinopiperidine, norfentanyl(M) |
| 198 | 2024-01 | Providence | white crystal | Crystal meth | Methamphetamine (S)* |
| 199 | 2023-12 | Providence | Pipe (black residue) | Unknown | Cocaine* (S) Delta-9-THC (C) Cotinine (A) Breakdown products/metabolites/intermediates of cocaine found: Benzoylecgonine*, norcocaine, ecgonine methyl ester, ecgonine, cocaethylene (M) |
| 200 | 2023-12 | Providence | Cooker (white powder) | Unknown | Fentanyl* (O) Methamphetamine* (S) Cocaine (S) Starting material and/or byproducts in fentanyl(s) production: 4-ANPP, Phenethyl-4ANPP(M) |
| 201 | 2023-12 | Providence | Cooker (purple powder) | Unknown | Xylazine* (A) Fentanyl* (O) Phenacetin (A) Cocaine (S) Acetylfentanyl (O) Beta-hydroxyfentanyl (O) Methamphetamine (S) Hydroxyzine (A) Starting material and/or byproducts in fentanyl(s) production: 4-ANPP, Phenethyl-4ANPP, 4-anilinopiperidine, N-methyl norfentanyl(M) |
| 202 | 2023-12 | Providence | Cooker (white powder) | Unknown | Fentanyl* (O) Acetylfentanyl (O) Para-fluorofentanyl (O) Cocaine (S) Starting material and/or byproducts in fentanyl(s) production: 4ANPP*, Phenethyl-4ANPP, Norfentanyl, 4-anilinopiperidine(M) |
| 203 | 2023-12 | Providence | Cotton (grey residue) | Unknown | Fentanyl* (O) Parafluorofentanyl (O) Acetylfentanyl (O) Xylazine (A) Caffeine (A) Cocaine (S) Lidocaine (A) Acrylfentanyl O) Starting material and/or byproducts in fentanyl(s) production: 4-ANPP*, Phenethyl-4ANPP*, 4-anilinopiperidine, despropionyl para-fluorofentanyl (M) |
| Sample | Month | City/Town | What was tested | Sold as | Substances found |
What do the substances mean?
You can learn more about the substances we found during our study in this glossary.
| Substance | Description |
|---|---|
| 4/N-ethylamphetamine | 4-ethylamphetamine and N-ethylamphetamine are designer drugs with similar structure to amphetamine and have amphetamine-like effects and risk. |
| 6-monoacetylcodeine | 6-monoacetylcodeine is an impurity sometimes seen in heroin. |
| 6-monoacetylmorphine (6-MAM) | 6-monoacetylmorphine (6-MAM or 6-AM) is an active heroin breakdown product. |
| Acetaminophen (Tylenol) | Acetaminophen (Tylenol) is a pain medication frequently added to drugs as an active cut. At standard doses it is safe, but in very high doses it can cause liver injury or failure. |
| Acetylfentanyl (or desmethyl fentanyl) | Acetylfentanyl (or desmethyl fentanyl) is a fentanyl analog. Acetylfentanyl can also be a byproduct in fentanyl synthesis. Based on studies in mice, acetylfentanyl is less potent than fentanyl. Acetylfentanyl has not been approved for pharmaceutical use and there have been no studies in humans on safety of use. Over the last decade acetylfentanyl has been reported in the drug supply and in fatal overdoses. In overdose, acetylfentanyl can cause sedation and decreased or stopped breathing. Naloxone will work to reverse overdose due to fentanyl and fentanyl analogues. |
| Acrylfentanyl (or acryloylfentanyl) | Acrylfentanyl (or acryloylfentanyl) is a fentanyl analog. Based on limited non-human data, its potency is reported similar to fentanyl. Acrylfentanyl has been reported in the drug supply over the last few years and since 2016, it has been involved in overdose deaths in Europe and the US. In overdose, acrylfentanyl can cause sedation and decreased or stopped breathing. Naloxone will work to reverse overdose due to fentanyl and fentanyl analogues. Because of its toxicity, lack of familiarity, inconsistent dose, and mixing into drugs which often already include fentanyl, overdose risk is high. |
| Aminophenazone | Aminophenazone is a pain medication no longer available for use in the US due to approximately 1% risk of skin rash and changes in blood cell lines, both of which can potentially be fatal. |
| Aminorex | Aminorex is a metabolite of levamisole with similar effects to amphetamines. Previously it was marketed as a stimulant/weight loss agent, but was removed from the market by the FDA due to concerns it caused high blood pressure in the lung (pulmonary hypertension). |
| Alprazolam (Xanax) | Alprazolam (Xanax) is a short-acting benzodiazepine often used to treat anxiety. In overdose it can cause heavy sedation, slowed or stopped breathing or unresponsiveness. The risk is higher if used with other sedating substances like opioids or alcohol. |
| Aripiprazole | Aripiprazole is an antipsychotic medication. |
| Benzoylecgonine | Benzoylecgonine is an inactive major breakdown product of cocaine. |
| Benzylfentanyl | Benzylfentanyl is a fentanyl analog with limited pharmacologic activity. It is used as a starting product to manufacture non-pharmaceutical fentanyl(s). |
| Beta-hydroxyfentanyl | Beta-hydroxyfentanyl is an active fentanyl analog and metabolite of fentanyl. The data on clinical effects in humans is very limited. Potency is unknown. |
| Bromazolam | Bromazolam is a designer benzodiazepine in the triazolobenzodiazepine class structurally related to alprazolam (Xanax), replacing the chlorine with a bromine. It has never been approved for medical use and data on pharmacology and toxicity is limited. Bromazolam has been identified in post-mortem toxicology in both Europe and the US. Drugs in the benzodiazepine class generally carry risk of tolerance and dependence with regular risk. Overdose can cause sedation and problems breathing, especially if combined with other sedating substances. |
| Bufotenine | Bufotenine (5-OH-DMT) is an alkaloid, closely related to psilocin, that is found in the skin secretions of genus Bufo toads and in certain South American plants. It is most often used for hallucinogen effects. |
| Buprenorphine | Buprenorphine (Suboxone/Subutex) is used to treat opioid use disorder or withdrawal. It is less likely than other opioids to cause overdose or decreased breathing, but in individuals without regular opioid use, it can cause overdose in excess. |
| Butyrylfentanyl | Butyrylfentanyl is a fentanyl analog. Based on limited data in mice, butyrylfentanyl is reported to be less potent than fentanyl. Butyrylfentanyl has never been approved for pharmaceutical use and there are no human studies on safety. Deaths have been reported with butyrylfentanyl exposure. In overdose, butyrylfentanyl can cause sedation and decreased or stopped breathing. Naloxone will work to reverse overdose due to fentanyl and fentanyl analogues. Because of its toxicity, lack of familiarity, inconsistent dose, and mixing into drugs which often already include fentanyl, overdose risk is high. |
| Caffeine | Caffeine is often added to drugs as active cut for stimulant effects or to enhance delivery. |
| Cannabinol (CBN) | Cannabinol (CBN) is an active cannabinoid in cannabis and can also be a breakdown product of Delta-9-THC. |
| Capsaicin | Capsaicin is an active component of chili peppers. It is used topically for pain control. Exposure to capsaicin can cause irritation of the eyes, mucous membranes, respiratory tract, and skin. |
| Carfentanil | Carfentanil is a synthetic opioid that is highly potent (10,000 times stronger than morphine and 100 times stronger than fentanyl). Carfentanil can lead to toxicity and overdose even with exposure to very small amounts, increasing risk for overdose death. Toxicity can lead to unresponsiveness and decreased or stopped breathing. Deaths have been reported associated with carfentanil exposure. |
| Carisoprodol | Carisoprodol is an FDA approved muscle relaxant. Sedation is the most common side effect. |
| Clonazepam (Klonopin) | Clonazepam is a long-acting benzodiazepine often use to treat anxiety. In overdose it can cause heavy sedation, slowed, or stopped breathing or unresponsiveness. The risk is higher if used with other sedating substances like opioids or alcohol. |
| Clonazolam | Clonazolam is a designer benzodiazepine. It is reported as one of the most potent of the designer benzodiazepines. It has never been approved for medical use and safety data in humans is limited. Its structure is similar to clonazepam, with an addition of a triazole ring. Drugs in the benzodiazepine class generally carry risk of tolerance and dependence with regular risk. Overdose can cause sedation and problems breathing, especially if combined with other sedating substances. |
| Cocaine | Cocaine is a stimulant. In overdose there is the risk of seizure, stroke, heart attack, abnormal heart rhythm, muscle breakdown, and/or kidney injury. |
| Codeine | Codeine is an opioid and can be used as a cough suppressant and pain medication. Codeine can sometimes be found in small amounts in heroin. |
| Cocaethylene | Cocaethylene is an active compound formed in the body when cocaine and ethanol are consumed together. Effects are similar to cocaine but last for longer periods of time. |
| Cotinine | Cotinine is the main active compound formed by nicotine breakdown. It is also naturally found in tobacco leaves. |
| Delta-9-THC | Delta-9-THC is the main psychoactive compound in cannabis. |
| Desalkylflurazepam | Desalkylflurazepam is a designer benzodiazepine first developed in the 1970s. It has never been approved for medical use and safety data in humans is limited. It is also a known metabolite of other designer benzodiapines such as flurazepam and has been documented as an impurity in midazolam (Versed). Based on mice data it is reported to be long-acting. Drugs in the benzodiazepine class generally carry risk of tolerance and dependence with regular risk. Overdose can cause sedation and problems breathing, especially if combined with other sedating substances. |
| Dextromethorphan | Dextromethorphan is available in many over the counter cough and cold preparations. It is a cough suppressant which has a central action on the cough center in the medulla. It is structurally similar to opioids but has no analgesic properties and little sedative activity. It is often used for hallucinogenic and euphoric effects (e.g., roboshot). In overdose can cause sedation, difficulty walking (ataxia), abnormal eye movements (nystagmus). Elevated heart rate, blood pressure, small pupils, nausea and vomiting have also been reported. In very large overdose can cause seizures, coma, and may cause serotonin syndrome if taken with other drugs. |
| Dextrorphan | Dextrorphan is a metabolites of dextromethorphan. It is an NMDA antagonist and acts as a cough suppressant. |
| Diphenhydramine (Benadryl) | Diphenhydramine (Benadryl) is an allergy medication frequently found as a cutting agent in drugs. In small doses the risk from diphenhydramine is low. |
| Disulfiram | Disulfiram is a medication used to treat alcohol use disorder. If consumed prior to alcohol intake it can cause severe symptoms of flushing, nausea, vomiting, low blood pressure, confusion, and heart problems. |
| Ecgonine | Ecgonine is a breakdown product of cocaine. It is also a compound found in coca leaves used to make cocaine. |
| Ecgonine methyl ester | Ecgonine methyl ester is an inactive cocaine breakdown product. |
| Ephedrine | Ephedrine is a stimulant with similar structure, effects, and risk profile as methamphetamine. It has been used as a precursor for methamphetamine manufacture. It was previously marketed as a weight loss agent and performance booster in the US, but its use was bannded due to safety risks, specifically heightened risk of stroke, abnormal heart rhythms, and death. Ephedrine can be synthesized or found naturally in the herb ephedra. Ephedra (aka Ma Huang) has been used in Traditional Chinese Medicine for hundreds of years. |
| Etonitazene | Etonitazene is a potent synthetic opioid that is a nitazene analog. Some studies suggest that etonitazene may be ten times more potent than fentanyl. Etonitazene causes opioid effects with use. Risk of overdose is high. Naloxone (Narcan) is effective in treating nitazene-related opioid overdose. Etonitazene will not be detected using fentanyl test strips or via standard drug testing. |
| Etizolam | Etizolam is a thienotriazolodiazepine derivative with a pharmacological profile similar to that of benzodiazepines. Etizolam is currently approved for therapeutic use in certain Asian and European countries, but is not FDA approved for use in the United States. Because etizolam is not regulated in the US and is found in fake pills sold as “Xanax” or mixed into other drugs, risk for adverse effects is heightened. Chronic etizolam use can lead to dependence and withdrawal if use is stopped. Reported toxicity includes confusion, discoordination, and slurred speech. Overdose can cause sedation and problems breathing, especially if combined with other sedating substances. |
| Fentanyl | Fentanyl is a highly-potent opioid with a high risk for overdose. In overdose it can cause problems with breathing and unresponsiveness. |
| Fentanyl analogs | Fentanyl analogs are drugs that are similar in chemical structure to fentanyl. Estimates of the potency of fentanyl analogs vary, but there is uncertainty because potency of illicitly manufactured fentanyl analogs is based on limited data and often has not been evaluated in humans. Deaths have been reported with exposure to the fentanyl analogs listed below. Because of the toxicity of these drugs, lack of familiarity, inconsistent dose, and mixing into drugs which often already include fentanyl, overdose risk is high. Fentanyl analogs in overdose can cause problems breathing and unresponsiveness. Fentanyl analogs found on testing in RI via testRI include: Acetylfentanyl, Acrylfentanyl, Butyrylfentanyl, Fentanyl methyl carbamate, Para-fluorofentanyl, Para-fluoroacetyl fentanyl, Phenylfentanyl and Methoxyacetylfentanyl. |
| Fentanyl methyl carbamate | Fentanyl methyl carbamate is a fentanyl analog. Data on pharmacology, clinical effects, and health risks is limited. Given the structural similarity to fentanyl, fentanyl methyl carbamate is expected to act like fentanyl and other opioids in overdose. Additional data is needed to better understand risk. |
| Fentanyl precursors | Fentanyl precursors/intermediates are used as starting materials or by-products in fentanyl(s) production. They have minimal pharmacologic activity and can include: 4-ANPP, Despropionyl para-fluorofentanyl, Despropionyl meta-methylfentanyl, N-methyl-norfentanyl, Norfentanyl, NPP, Phenethyl-4-ANPP, Anilino-1-benzylpiperidine, Benzylfentanyl. |
| Flualprazolam | Flualprazolam is a designer benzodiazepine. Flualprazolam has been noted in counterfeit pills in Europe and listed as a contributing factor in drug overdose deaths. In mice studies flualrazolam was found to be more potent than alprazolam (Xanax). Its structure is similar to alprazolam with substitution of a fluorine. It has never been approved for medical use and safety data in humans is limited. Drugs in the benzodiazepine class generally carry risk of tolerance and dependence with regular risk. Overdose can cause sedation and problems breathing, especially if combined with other sedating substances. |
| Flubromazolam | Flubromazolam is a designer benzodiazepine. It is reported as one of the most potent of the designer benzodiazepines. It has never been approved for medical use and safety data in humans is limited. Drugs in the benzodiazepine class generally carry risk of tolerance and dependence with regular risk. Overdose can cause sedation and problems breathing, especially if combined with other sedating substances. |
| Gabapentin | Gabapentin is used to treat chronic pain or nerve pain. Gabapentin, especially if combined with other sedating substances, can cause sedation. |
| Heroin | Heroin is an opioid which in overdose can cause unresponsiveness, slowed or stopped breathing. Heroin is less potent than fentanyl. |
| Hydroxyzine | Hydroxyzine is an allergy medication sometimes used as a sleep aid that can cause sedation. |
| Isotonitazene | Isotonitazene is a potent synthetic opioid that is a nitazene analog. It is estimated that isotonitazene may be five times more potent than fentanyl based on studies in animals and cells. Isotonitazene causes opioid effects with use. Risk of overdose is high. Naloxone (Narcan) is effective in treating nitazene-related opioid overdose. Isotonitazene will not be detected using fentanyl test strips or via standard drug testing. |
| Ketamine | Ketamine is an anesthetic that is similar to PCP. Ketamine is often used for its hallucinogenic effects. Ketamine can cause hallucinations, confusion, abnormal behavior, nausea or vomiting, and hypertension. Depending on the dose, it can also cause breathing changes, sedation, abnormal heart rate, seizures or abnormal heart rhythm. Chronic use has been associated with bladder and urinary tract problems. |
| Levamisole | Levamisole is a medication used to treat worm infections. It is a frequent cut found in cocaine. It can cause problems with blood cells, blood vessels, and/or lead to rashes. |
| Lidocaine | Lidocaine is a local anesthetic/numbing agent (e.g., used in dentist offices and for topical pain relief). Lidocaine is a common cut in drugs. At standard doses it is safe, but in very high doses can cause heart problems and/or seizures. |
| MDA | MDA (3,4-methylenedioxyamphetamine) is a hallucinogenic amphetamine, similar to MDMA. Adverse effects include dizziness, hyperactivity, decreased appetite, pupillary dilation, headache, anxiety, and disorientation. Rare severe toxic effects include low sodium, seizures, elevated body temperature, muscle rigidity, and muscle and kidney injury. The compound has mostly stimulant effects with lesser hallucinogenic properties. It is also a minor metabolite of MDMA. Deaths have been reported with overdose of MDA. |
| MDDMA | MDDMA (3,4-Methylenedioxy-N,N-dimethylamphetamine) is a hallucinogenic amphetamine, similar to MDMA. Data on adverse effects are limited, but likely similar to MDMA and other hallucinogenic amines. Based on chemical structure it is thought to have reduced activity compared to MDMA. |
| MDMA | MDMA (3,4-Methylenedioxymethamphetamine) is a hallucinogenic amphetamine. Adverse effects include dizziness, hyperactivity, decreased appetite, headache, anxiety, and disorientation. Rare severe toxic effects include low sodium, seizures, elevated body temperature, and muscle and kidney injury. |
| MDMB-4en-PINACA | MDMB-4en-PINACA is a synthetic cannabinoid. Synthetic cannabinoids are chemically manufactured drugs designed to mimic cannabinoids. These are often associated with unknown biological effects and health risks because they have not been studied in humans. Reported adverse effects of MDMB-4en-PINACA include loss of consciousness, unresponsiveness, cardiovascular effects (such as elevated blood pressure, fast heart rate, heart attack), stroke, seizures, vomiting, kidney injury, delirium, psychosis, and aggressive and violent behavior. MDMB-4-en-PINACA exposure has been involved in severe poisoning and/or death in multiple cases. In most of the deaths it was mixed in with other substances. |
| Melatonin | Melatonin is a hormone that can regulate circadian rhythms and sleep. It is commonly used in treatment of sleep disorders and jet lag. Adverse effects from exposure would not be expected. |
| Mepivicaine | Mepivicaine is a local anesthetic/numbing agent (it is often used in dentist offices and for topical pain relief). Due to their numbing effects, local anesthetics are often used as cut in drugs. At standard doses it is safe, but in extremely high doses can cause heart problems and/or seizures. |
| Methadone | Methadone is an opioid used to treat opioid use disorder and pain. In overdose it can cause problems with breathing and unresponsiveness. It can also cause abnormal heart rhythms at high doses. |
| Methamphetamine | Methamphetamine is a stimulant. Risks include heart problems (e.g., abnormal heart rhythm or rate, heart attack, heart failure), high blood pressure, hallucinations, psychosis, and kidney and/or muscle injury. |
| Methcathinone (ephedrone) | Methcathinone (ephedrone) is a synthetic cathinone derivative. Methcathinone was originally produced as an appetite suppressant, but was never marketed. Methcathinone has been used widely in Russia and across Europe, less commonly in the US. Synthetic cathinones, such as methcathinone, are structurally similar to cathinone, a psychoactive stimulant found in the khat plant. Behavioral effects are similar to methamphetamine and amphetamine. |
| Metonitazene | Metonitazene is a potent synthetic opioid in the nitazene class. Nitazenes cause opioid effects and are reversible with naloxone. Within the nitazene class potency can vary. Metonitazene has a potency similar to fentanyl. Other nitazenes, such as protonitazene and isotonitazene have potency exceeding fentanyl. |
| Methoxetamine | Methoxetamine is a hallucinogen similar to ketamine. Data on clinical effects and safety are limited. |
| Methoxyacetylfentanyl | Methoxyacetylfentanyl is a fentanyl analog. Based on limited animal data, it is less potent than fentanyl. Methoxyacetylfentanyl has never been approved for pharmaceutical use and there are no human studies on safety. Deaths have been reported with exposure. In overdose, methoxyacetylfentanyl can cause sedation and decreased or stopped breathing. Naloxone will work to reverse overdose due to fentanyl and fentanyl analog. Because of its toxicity, lack of familiarity, inconsistent dose, and mixing into drugs which often already include fentanyl, overdose risk is high. |
| Midazolam (Versed) | Midazolam (Versed) is a short-acting benzodiazepine. In overdose it can cause heavy sedation, slowed or stopped breathing or unresponsiveness. The risk is higher if used with other sedating substances like opioids or alcohol. |
| Morphine | Morphine is an opioid. In overdose it can cause breathing problems and sedation or unresponsiveness. |
| N-desmethyltramadol | N-desmethyltramadol is an inactive product of tramadol metabolism (breakdown). |
| Nicotinamide (niacinamide) | Nicotinamide is a form of vitamin B3, a water soluble vitamin. Rare cases of liver toxicity have been reported with use. |
| Nicotine | Nicotineis often added to drugs as active cut for stimulant effects. |
| Nitazenes | Nitazenes (or nitazene analogs) are a novel class of opioids. Potency of nitazenes vary from less than fentanyl to significantly more potent. There are no approved medical uses of nitazenes in the US. Nitazenes cause opioid effects and risk of overdose from nitazene exposure is high. Naloxone (Narcan) is effective in treating nitazene-related opioid overdose. Nitazenes have a different structure than other opioid classes and are not detected using standard drug testing. Nitazenes are not detected using fentanyl test strips or urine drug screen immunoassays. |
| N,N-dimethyltryptamine (DMT) | N,N-dimethyltryptamine (DMT) is a short-acting hallucinogen structurally related to serotonin. DMT occurs naturally in some plants, can be prepared synthetically, and is also a component of ayahuasca. Toxic effects include hallucinations, anxiety, agitation, seizure, perceptual distortions, dilated pupils, and high blood pressure. Psychosis has also been reported. |
| Noscapine | Noscapine is a compound in the poppy plant that has been used as a cough medicine. It is frequently found as an impurity in heroin. Adverse effects can include nausea, dizziness, headache, tremor, and rash. |
| Norcocaine | Norcocaine is an active breakdown product of cocaine. |
| Norketamine | Norketamine is the main active breakdown product of ketamine and has a similar effect and risk profile. |
| O-desmethyltramadol | O-desmethyltramadol is an opioid and the main active metabolite of tramadol. In addition to typical opioid effects it can sometimes cause seizures and/or hypoglycemia. |
| Oxycodone | Oxycodone is an opioid. In overdose it can cause breathing problems and sedation or unresponsiveness. |
| Papaverine | Papaverine is a compound found in the opium poppy; it is a frequent contaminant of heroin. Adverse reactions include headache, nausea, dizziness, sweating. If injected low blood pressure and slowed heart rate can occur. |
| Para-bromofentanyl | Para-bromofentanyl is a fentanyl analog. It has been recently documented in the US and Canadian drug supply. Data on clinical effects in humans is limited. Potency is unknown. |
| Para-fluoroacetyl fentanyl | Para-fluoroacetyl fentanyl is a fentanyl analog. Data on clinical effects in humans is limited. Potency is unknown. |
| Para-fluorofentanyl (or 4-fluorofentanyl) | Para-fluorofentanyl (or 4-fluorofentanyl) is a fentanyl analog. Based on limited data, its potency is lower than fentanyl. Para-fluorofentanyl is most often found in combination with fentanyl but the amount can vary. Para-fluorofentanyl has been reported with increasing frequently in the drug supply since 2020 and has resulted in overdose fatalities. In overdose, para-fluorofentanyl can cause sedation and decreased or stopped breathing. Naloxone will work to reverse overdose due to fentanyl and fentanyl analogs. Because of its toxicity, lack of familiarity, inconsistent dose, and mixing into drugs which often already include fentanyl, overdose risk is high. |
| Para-fluoro valeryl fentanyl | Para-fluoro valeryl fentanyl is a fentanyl analog. The data on clinical effects in humans is very limited. Potency is unknown. |
| Phenacetin | Phenacetin is a common cutting agent in drugs and is a pain reliever. With chronic exposure it can cause kidney and/or liver problems. |
| 2-phenethylamine | Phenethylamine is a naturally occurring substance in humans and can also be made synthetically. It can be purchased as a dietary supplement. It has stimulant properties. |
| Phenylfentanyl (benzoylfentanyl) | Phenylfentanyl (benzoylfentanyl) is a fentanyl analog. In a single mouse study it demonstrated lower potency than morphine. Data on clinical effects in humans is limited. |
| Phentermine | Phentermine is an amphetamine used to treat obesity. Side effects are similar to other amphetamines. Severe toxicity is rare except in overdose or chronic use. Risks include heart problems (e.g., abnormal heart rhythm or rate, heart attack, heart failure), lhigh blood pressure, hallucinations, psychosis, and kidney and/or muscle injury. |
| Pholedrine (4-hydroxymethamphetamine) | Pholedrine (4-hydroxymethamphetamine) is a stimulant used in medicine to increase blood pressure and as an eye drop to cause pupillary dilation. Pholedrine is also a minor breakdown product of methamphetamine. |
| Procaine | Procaine is a local anesthetic/numbing agent (e.g., used in dentists offices and for topical pain relief). At standard doses it is safe, but in extremely high doses can cause heart problems and/or seizures. |
| Promethazine | Promethazine is used to treat nausea, vomiting, and motion sickness. It is also used for sedation. Promethazine acts via inhibition of histamine receptors and also has anticholinergic effects. In excess can cause sedation. Also reported dilated pupils, agitation, elevated heart rate, delirium, dry skin, urinary retention. Overdose is rare. Skin necrosis has been reported with IV use. |
| Protonitazene | Protonitazene is a novel synthetic opioid structurally similar to isotonitazene. In-vitro data suggests potency of protonitazene to be slightly greater than fentanyl. It has never been approved for medicinal use. Clinical data is limited, but would expect opioid effects and elevated risk for overdose. |
| Psilocin | Psilocin (4-OH-DMT) is an alkaloid found in psychedelic mushrooms (Psilocybe). Effects include hallucinations, through disorders, and mood changes. This compound is currently being explored as a psychotherapy adjunct. |
| Pyridoxine | Pyridoxine Vitamin B6 (pyridoxine) is a water soluble vitamin. It serves many functions in the body and with exposure to small amounts unlikely to have clinical effects. |
| Quetiapine | Quetiapine is an antipsychotic that can cause sedation or unresponsiveness. |
| Quinine/Quinidine | Quinine/Quinidine is a common cutting agent in heroin/fentanyl. It is a drug used for the treatment of malaria. At amounts typically found in drug samples, the risks are low. At very high doses, risks include kidney damage, ringing in the ears, nausea, vomiting, diarrhea, platelet problems and hypotension (if injected), and heart problems. |
| Sulfamethoxazole | Sulfamethoxazole is an antibiotic. Nausea and vomiting, decreased appetite and allergic skin reactions (e.g., rash) are the most common adverse effects. |
| Theobromine | Theobromine naturally occurs in the cocoa plant. It is present in most forms of chocolate. |
| Tramadol | Tramadol is an opioid that is often prescribed for pain. Recently, it has been found as an active cut in the drug supply. In addition to typical opioid effects, tramadol can sometimes cause seizures and/or hypoglycemia. |
| Trazodone | Trazodone is an antidepressant that has anxiolytic and sedating properties. The most common side effect is sedation. In large doses can cause nausea, vomiting, muscle twitching, lethargy, coma. Rare reports of abnormal heart rhythms and priapism (unwanted persistent erection) can occur. |
| Xylazine | Xylazine is a veterinary sedative. Xylazine is a long-acting and sedating medication, but it is not an opioid. Especially if combined with other sedating medications it can cause unresponsiveness, low blood pressure, a slowed heart rate, and decreased breathing. Xylazine use has been associated with skin ulcers and wounds. Chronic use can also lead to dependence and a withdrawal syndrome that can cause irritability, anxiety, and dysphoria. |
More Resources
Resources for safer drug use
In Rhode Island, you can already get supplies and services to stay safer when you use drugs. Find out where you can get syringes, naloxone, fentanyl test trips, and get tested for HIV and hepatitis C.
Safer drug use practices
Learning to take care of yourself takes time and thought. There are many that you can do to help you use drugs more safely. This includes resources in the community that you can access, as well as general suggestions to prevent overdose and infection.